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Alyson Rose-Wood: How Can HIV Care Transition Be Improved When U.S. Immigration and 
Customs Enforcement Repatriates Detained Aliens to Mexico?  
(Under the direction of Sandra Greene) 
 
Given the seriousness of HIV infection, the clinical implications of interrupted antiviral 
therapy, and the availability of free HIV treatment in Mexico, continuity of care for HIV-infected 
aliens detained by U.S. Immigration and Customs Enforcement (ICE) who are repatriated to 
Mexico is important. While ICE provides opt-in HIV screening and treatment for aliens during 
detention, a major gap exists in the care transition for HIV-infected detainees once they are 
repatriated from the United States.  
A convergent mixed-methods design was used to address how care transition of HIV-
infected aliens repatriated to Mexico could be improved. The number of HIV-infected aliens 
repatriated to Mexico annually was estimated using data on HIV prevalence rates among aliens 
in ICE detention from the Texas Department of State Health Services. U.S.-based key informants 
were interviewed about HIV care transition and the factors facilitating or hindering its success. 
Bardach’s eightfold path was used to identify policy solution(s). Kingdon’s multiple streams 
model was used to develop policy advocacy recommendations to take advantage of “windows of 
opportunity” to reach identified policy goals.  
Secondary data analysis found that while likely an underestimate, every two weeks ICE is 
repatriating 2-3 (avg) HIV-infected aliens to Mexico. Ways to improve care transition suggested 
by key informants included ensuring that U.S. and Mexican health authorities are included in the 
removal of HIV-infected aliens in ICE custody and addressing three challenges for binational 
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HIV medical record sharing (access, confidentiality, and patient consent). The policy analysis 
found that the most impactful long-term option for improving HIV care transition is to develop a 
binational continuity of care program that includes a platform for sharing medical information. A 
short-term step is to ensure implementation of extant ICE standards for HIV care transition. The 
multiple streams model suggested possible avenues to promote program implementation such as 
engaging with advisory committees that advise the U.S. government on HIV care.  
The most impactful option for improving HIV care transition is the development of a 
binational platform for sharing of HIV data and medical records. Opportunities to move this 
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CHAPTER 1: INTRODUCTION 
 
Statement of the Issue 
The Immigration and Nationality Act (INA) (INA, 1952) contains many of the most 
important provisions of U.S. immigration law amended over the years. The last significant INA 
amendment occurred in 1996 with the enactment of the Illegal Immigration Reform and 
Immigrant Responsibility Act, or IIRIRA (IIRIRA,1996). IIRIRA changes to the INA included 
mandating the placement of every illegal alien convicted of an aggravated felony in expedited 
removal proceedings. As a result, the number of aliens held in immigration detention in the 
United States of America (United States) has grown significantly between 1996 and 2020.  
In fiscal year (FY) 2019, the average daily population of illegal aliens maintained in adult 
or family U.S. detention facilities was 50,165 (U.S. Immigration and Customs Enforcement 
Agency [ICE], 2019). This total was across more than 225 facilities, mostly state and county 
jails, but also corporate detention centers and 23 facilities run by ICE (U.S. Department of 
Homeland Security [DHS], 2019). Aliens are incarcerated while awaiting judicial or legal 
proceedings or transportation to their country of citizenship.  
ICE manages health-care provision for adults (18 years or older) and families in 
immigration detention centers. Despite the wide variety of physical settings, each detention 
facility contains a medical unit where detainees receive medical care under a common set of 
administrative ICE rules (ICE Health Service Corps [IHSC], 2019). According to ICE guidance, 
detainees should receive a health intake screening within 12 hours of arrival as well as a 
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comprehensive health assessment within two weeks of detention (ICE, 2011, 2019). In FY 2019, 
the average length of detention in ICE facilities was just under eight weeks (54.5 days) (ICE, 
2019). The INA instructs DHS to detain aliens ordered to be removed and to remove them from 
the United States within 90 days. However, no statutory limitation exists on the amount of time 
DHS may detain an alien while removal proceedings are pending.  
According to DHS, since 2001, the United States has removed more than 4.5 million 
aliens, primarily of Mexican origin (DHS, 2019). In FY 2019, 48% of all aliens removed by ICE 
were from Mexico (ICE, 2019). Table 1 presents the total number of aliens removed in FY 2018 
and FY 2019 across the top four countries of citizenship. 
 
Table 1. Aliens Removed by ICE, Top Four Countries of Citizenship (FY 2018, 2019) 
 
Source: U.S. Immigration and Customs Enforcement, FY 2019 Enforcement and Removal Operations Report. 
 
Most aliens removed by ICE to Mexico are transferred to land border crossings located 
along the U.S.-Mexico border. It is the U.S. government’s responsibility to get them to a drop off 
point but not their final destination (DHS, 2019). Removed aliens are typically released into the 
general community of these border crossings with little to no support or resources. DHS statistics 
show that removal from the United States, particularly for those aliens repatriated to Mexico, 
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does not mean that the alien will never again be a member of a U.S. community. In FY 2019, 
U.S. Custom and Border Patrol’s (CBP) Office of Border Patrol reported that 7% of individuals 
were apprehended more than one time by CBP within the same year (CBP, 2019). Out of the 
188,382 criminal aliens removed by ICE in 2011, at least 86,699, or 46%, had been repatriated 
earlier and had illegally returned to the United States (ICE, 2019). Once a removed alien 
completes an illegal U.S. reentry, in nearly all cases, the alien will go undetected unless charged 
with another crime or if the alien is recognized by local law enforcement officials. Thus, the 
number of aliens who make an illegal reentry is higher than DHS data indicate. 
Transition in Responsibility for Enforcing the INA  
Before March 1, 2003, the responsibility for enforcing the INA belonged solely to the 
Immigration and Naturalization Service (INS). The INS was an agency within the Department of 
Justice, and ultimate legal authority under the INA, residing in the attorney general’s office. The 
CBP, although often referred to as an independent entity, was a division of the INS. 
With the creation of DHS on March 1, 2003, authority over the INA was transferred to 
the Secretary of Homeland Security (Homeland Security Act, 2002). DHS split the INS into 
three agencies: U.S. Immigration and Customs Enforcement (ICE), U.S Customs and Border 
Protection (CBP), and U.S. Citizenship and Immigration Services (USCIS). All three agencies 
now share responsibility for enforcing the INA. USCIS does not arrest aliens, but it puts aliens 
into removal proceedings. Although both ICE and CBP arrest aliens, ICE is solely responsible 
for detaining aliens during the removal process. CBP does not detain aliens beyond the time 
spent at the processing station. If CBP decides to detain an alien, then that alien is turned over to 
ICE for further action. ICE is the agency primarily responsible for immigration enforcement 
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efforts in the interior of the United States. The Health Service Corps (IHSC), a division within 
ICE, provides health oversight for detainees. 
Current Immigration Enforcement Policies 
On January 25, 2017, President Donald J. Trump issued Executive Order (EO) 13768, 
Enhancing Public Safety in the Interior of the United States, which set forth the Administration’s 
immigration enforcement and removal priorities (Office of the Press Secretary, 2017). DHS’ 
February 20, 2017, implementation memorandum, Enforcement of the Immigration Laws to 
Serve the National Interest, provided further direction for implementing policies set forth in the 
EO (DHS, 2017). Together, the EO and implementation memorandum expanded ICE’s 
enforcement focus to include removable aliens who: 1) have been convicted of a criminal 
offense; 2) have been charged with a criminal offense that has not been resolved; 3) have 
committed acts which constitute a chargeable criminal offense; 4) have engaged in fraud or 
willful misrepresentation in connection with any official matter before a governmental agency; 
5) have abused any program related to receipt of public benefits; 6) are subject to a final order of 
removal but have not complied with their legal obligation to depart the United States; or 7) in the 
judgment of an immigration officer, otherwise pose a risk to public safety or national security.  
ICE Health Care 
ICE is responsible for providing medical care to all aliens in its custody and pays all 
health care costs for detained aliens (IHSC, 2019). According to ICE guidance, detainees should 
receive a health intake screening upon arrival as well as a comprehensive health examination 
conducted by a health care practitioner within 14 days of arrival (ICE, 2011, 2019). This 
comprehensive assessment includes both physical and mental health screenings. Detention 
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facilities are not required to provide assessments to any detainee who has had a documented 
comprehensive health assessment conducted by ICE within the last 90 days. 
IHSC provides direct on-site patient care to those aliens in dedicated ICE detention 
facilities (note: this does not include facilities with which ICE has intergovernmental service 
agreements, such as state and local law enforcement facilities). In FY 2019, IHSC provided 
direct patient care to approximately 16,500 ICE detainees at 23 detention facilities (DHS, 2019). 
IHSC manages health care services at these 23 facilities via an electronic health records system 
(IHSC, 2019). The contracted detention vendor typically handles health care at the remaining 
ICE detention facilities either on-site, where costs are included in the detention contract, or off-
site, where costs are processed by the VA Finance Services Center, approved by IHSC, and paid 
for by ICE (DHS, 2019). IHSC provides health oversight for detainees housed at these facilities.  
ICE detention standards govern the conditions of confinement, program operations, and 
management expectations within the immigrant detention system (ICE, 2000, 2011, 2019). The 
detention standards include medical care requirements for aliens detained for more than 72 
hours. The most recent standards covering the medical care requirements are as follows: 1) the 
2011 Performance-Based National Detention Standards (PBNDS), which applies to facilities 
within the ICE detention system (used only for immigrant detention) and 2) the 2019 National 
Detention Standards (NDS), which update the 2000 National Detention Standards that are 
applied to all facilities not used solely for immigrant detention such as state and county jails. 
IHSC follows the 2011 PBNDS at all facilities other than family residential centers where, 
instead, Family Residential Standards apply. See Table 2 for the medical care requirements in the 




Table 2. Current U.S. Immigration and Customs Enforcement Detention Standards 
Covering the Medical Care Requirements for Aliens Detained for More than 72 Hours 
 Applies to all “non-dedicated facilities” 
that are not solely used for immigration 
detention 
Applies to facilities within the ICE 
detention system (only used for 
immigrant detention) 
 
 ICE’s National Detention Standards*** 
(2019)  
ICE’s Performance-Based National 
Detention Standards** (2011) 
Health intake 
screening 
Detainees should receive a medical screening 
(no later than 12 hours after arrival). 
Detainees should receive a medical 





Comprehensive health assessment done 
within 14 days of arrival at facility. 
Comprehensive health assessment done 




Bloodborne Pathogens (Section N), HIV 
(part 2, 3):  
• A detainee may request HIV testing at any 
time.  
• All detainees with HIV shall be evaluated 
for TB disease. 
Bloodborne Pathogens (Section 4):  
• A detainee may request HIV testing at 
any time.  
• All detainees with HIV shall be 




• Upon arrival, detainees will receive TB 
screening. 
• All detainees with suspected or confirmed 
TB disease shall be evaluated for HIV. 
• Upon arrival, detainees will receive TB 
screening. 
• All detainees with suspected or 
confirmed TB disease shall be evaluated 
for HIV. 
State and federal 
reporting of 
HIV, AIDS, TB 
diagnoses 
• New HIV-positive diagnoses must be 
reported to U.S. government bodies 
according to state and local laws and 
requirements.  
• The facility must have written plan(s) that 
address the reporting and collaboration 
with local or state health departments. 
• Each facility shall establish a written 
plan for the management of HIV 
infection, including reporting to state 
and local health departments.  
• The detention facility must report all TB 




• Pursuant to facility policy, copies of 
medical records may be released by the 
facility health care provider directly to a 
detainee, or a person designated by the 
detainee, upon written authorization from 
the detainee (no specific form).  
• After release from ICE detention, a 
detainee may submit an FOIA request for 
copies of medical records.    
• Copies of health records shall be 
released directly to a detainee or their 
designee, at no cost to the detainee, 
within a reasonable timeframe after 
receipt of a written request from the 
detainee. 
• After release from ICE detention, a 
detainee may submit an FOIA request 






Detainee will be provided medication (15-
day supply for TB, up to a 30-day supply for 
HIV/AIDS), referrals to community-based 
providers, and a medical care summary.  
The detainee will be provided medication 
(at least a 15-day supply for TB, at least a 
30-day supply for HIV/AIDS), referrals to 
community-based providers, medical care 
summary. 
*Original NDS issued by the Department of Justice’s Immigration and Naturalization Service, ICE’s predecessor.  
** ICE revised the 2011 PBNDS in 2013 and 2016; this table reflects the 2016 updated version. 
***This 2019 version of the 2000 NDS applies to the ICE Intergovernmental Service Agreement facilities, U.S. 




Once ICE takes custody of an alien, policy requires that person be given a risk 
classification assessment (RCA) as early in the process as possible unless the alien is subject to 
mandatory detention or will be removed within five days (ICE, 2011). The RCA was developed 
to assist with creating uniformity in custody and release decisions. 
The RCA contains questions on personal details, encounter details, supporting 
information, the risk to public safety, special vulnerabilities, and the risk of flight (ICE, 2011). 
The RCA places serious illnesses under the “special vulnerabilities” category. The instructions 
for the RCA under “Serious Physical Illness” state, “Assess whether the individual has been 
diagnosed or claims to have a serious physical illness such as diabetes, seizures, HIV, AIDS, 
heart problems, cancer, epilepsy, tuberculosis, or other serious illness.” If the RCA recommends 
detention but the alien has a serious medical condition, then they are referred to a supervisor for 
a decision on whether to detain or release that person. 
Upon release or removal from ICE custody, the 2011 PBNDS and the 2019 NDS require 
that the detainee be provided medication, referrals to community-based providers as medically 
appropriate (the guidelines do not clarify if the providers are in the place of arrival of the alien 
being repatriated or in the home geographical area of the repatriated alien), and a detailed 
medical care summary. This summary should include instructions that the detainee can 
understand and health history that would be meaningful to future medical providers (ICE, 2011, 
2019). 
ICE Health Care: Tuberculosis  
The primary way that ICE identifies the presence of tuberculosis (TB) is through the 
health screening performed when an alien is placed in detention for more than 72 hours (ICE, 
2011, 2019). The 2011 PBNDS and the 2019 NDS require that all aliens receive a TB screening 
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following CDC guidelines within 12 hours of arriving at the detention facilities. A medical 
professional or a specially-trained detention officer may administer the screening. Detainees with 
possible TB symptoms are placed in a functional airborne infection isolation room with negative 
pressure ventilation and are evaluated for TB disease. If the TB screening is negative and the 
detainee is asymptomatic, the detainee can join the general population of detainees. Detention 
facilities are not required to screen detainees in the continuous custody of a law enforcement 
agency and who have a documented TB screening within the past six months. Annual TB tests 
are required for any alien in detention for more than one year.  
For TB, the 2011 PBNDS require the following: 
Detainees with symptoms suggestive of TB, or with suspected or confirmed active TB 
disease based on clinical and/or laboratory findings, shall be placed in a functional 
airborne infection isolation room with negative pressure ventilation and be promptly 
evaluated for TB disease. Patients with suspected active TB shall remain in airborne 
infection isolation until determined by a qualified provider to be noncontagious in 
accordance with CDC guidelines. (ICE, 2011) 
 
The 2011 PBDNS and the 2019 NDS include numerous procedural safeguards for 
managing confirmed and suspected cases of active TB (ICE, 2011). For instance, the detention 
facility must report all TB cases to state or local health departments. The facility must also notify 
the IHSC Public Health, Safety, and Preparedness Unit (PHSP) and provide biographical 
information, a case summary report, and a treatment status and start date. The detention facility 
must notify the IHSC PHSP of any hospitalizations, facility transfers, releases, or removals of 
the person with TB. ICE typically does not treat detainees for latent TB infection unless they 
have a complicated condition, such as HIV.  
When ICE removes a detained alien who has TB from the United States, the detention 
facility is required to coordinate with the IHSC PHSP to help ensure continuity of care (ICE, 
2011). This typically occurs through a referral to the health department in the receiving country. 
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ICE has no authority to enforce this referral, either on the part of the alien or the part of the 
foreign government or health department.  
According to the 2011 PBDNS and the 2019 NDS, detainees must be educated about 
their TB treatment and provided with a 15-day supply of medications when transferred, released, 
or removed (ICE, 2011, 2019). Once in their country of origin, aliens may travel to, or reside in, 
a location where they have limited access to health care, have limited funding to buy medication 
and pay for treatment or cease treatment if they do not feel sick. Providing a 15-day supply of 
TB medications is an effort to address concerns about incomplete TB disease treatment after 
removal. Interrupted TB treatment can result in a return to a contagious state, acquired drug 
resistance, transmission of the disease, and poor outcomes, including death (CDC, 2019).   
In November 2002, the Advisory Committee for the Elimination of Tuberculosis (ACET) 
recommended that a working group be formed to review problems with post-detention TB 
treatment of aliens. ACET recommended that removal should only occur after verifying that 
necessary treatment is available at the destination (Nolan et al., 2003). In 2004, ICE implemented 
a policy allowing for a temporary “medical hold” so that the IHSC could arrange for continuity 
of care before removal (Fenton & Castro, 2006). In 2005, ICE formalized policies for referring 
medical cases to two organizations: CureTB (San Diego County Health Department, San Diego, 
CA) or TB Net (Migrant Clinicians Network, Austin, TX) (Schneider & Lobato, 2007).  
TB Net, created by the Migrant Clinicians Network in 1996, provides continuity of care 
through case management of highly mobile TB patients, such as repatriated aliens (Combellick et 
al., 2011). According to TB Net, aliens make at least two major moves: from the detention center 
to their country of origin and/or from their place of arrival to their home in their country of 
origin. TB Net uses a caseworker to keep in telephone contact with the repatriated patients and 
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with their health care provider (located at their place of final destination after repatriation) to 
ensure that the patient is continuing treatment. 
CureTB is “a referral and continuity of care program for tuberculosis patients and their 
contacts who travel between the United States, Mexico, and Central America” (San Diego 
County Health and Human Services Agency, 2019). CureTB functions as an information 
exchange and facilitation service. It educates aliens and connects them with TB clinics in their 
destination country and provides clinical information to the receiving clinics. CureTB also 
provides follow-up case information to the referring entity every two months and a final report 
after 12 months.  
Notable differences exist between TB Net and CureTB. TB Net requires patient consent 
as a prerequisite for enrollment in the program. No written patient consent is required for 
enrollment in CureTB, just a provider referral. TB Net has more contact with deported TB 
patients, while CureTB is more involved in active case management, such as reviewing treatment 
plans and records.  
Removal from the United States presents many challenges to TB treatment. In 2001, 
CDC noted, “One of the most challenging tasks in managing TB among detainees is the 
coordination of care during the post-detention period in the United States or in the patients’ 
countries of origin” (Saunders et al., 2001). The fact that different countries use different 
definitions for active TB complicates the international referral process. The situation could result 
in repatriated aliens with TB no longer receiving treatment once they arrive in their country of 
citizenship. For example, a case diagnosed as active TB in the United States might not be active 
TB in Mexico. To help address this, CDC worked with its Mexican counterparts to create a 
binational case definition that was finalized in 2018 (Woodruff et al., 2018). 
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ICE Health Care: HIV/AIDS 
The two broad categories of HIV-related activities within the ICE health care system are 
screening for HIV and care for detainees living with HIV/AIDS. For HIV/AIDS, the 2011 
PBNDS and the 2019 NDS require opt-in HIV screening (i.e., requested by the detainee) or relies 
on the detainee to share information on HIV/AIDS-infection upon arrival to detention (ICE, 
2011, 2019). The exception is for cases where a detainee has active TB. In the latter case, the 
detainee must be evaluated for possible HIV infection.  
According to the 2011 PBNDS, the following must occur: 
A detainee may request HIV testing at any time during detention. Facilities shall develop 
a written plan to ensure the highest degree of confidentiality regarding HIV status and 
medical condition. Staff training must emphasize the need for confidentiality, and 
procedures must be in place to limit access to health records to only authorized 
individuals and only when necessary. The accurate diagnosis and medical management of 
HIV infection among detainees shall be promoted. An HIV diagnosis may be made only 
by a licensed health care provider, based on a medical history, current clinical evaluation 
of signs and symptoms, and laboratory studies. Clinical Evaluation and Management 
Personnel shall provide all detainees diagnosed with HIV/AIDS medical care consistent 
with national recommendations and guidelines. Medical and pharmacy personnel shall 
ensure the facility maintains access to adequate supplies of FDA-approved medications 
for the treatment of HIV/AIDS to ensure newly admitted detainees shall be able to 
continue with their treatments without interruption. (ICE, 2011) 
 
Since 1987, CDC has regularly reported in the literature on HIV concerns in prisons 
(Westergaard et al., 2013). In contrast, relatively little research has examined HIV in U.S. 
immigration detention centers. According to Venters et al. (2009), ICE does not record, monitor, 
nor report information about HIV tests nor statistics concerning the percentage of positive tests, 
the stage of HIV at diagnosis, treatment initiation, and follow-up. Because ICE does not have a 
mandate to provide statistics on HIV, limited data are available on HIV testing and medical care 
for detainees. In other words, while ICE has an ongoing active TB surveillance program, it does 
not have one for HIV. One reason for this difference could be that ICE personnel are at-risk for 
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TB infection, whereas ICE personnel who feed, escort, directly supervise, or conduct routine 
office work with HIV patients are not considered at risk for HIV infection from a detainee.  
Maintaining uninterrupted HIV continuity of care among aliens removed from the United States 
is challenging. While ICE policy requires that repatriated aliens be given up to a 30-day supply 
of HIV/AIDS medication and be provided with a medical care summary, ICE referrals do not 
routinely happen for HIV. 
Why Compare Active TB and HIV/AIDS?  
Several similarities exist between how HIV/AIDS and active TB are handled within ICE 
detention that have led this investigator to learn from the TB care transition model informing the 
HIV care transition model as follows: 
• ICE requires HIV screening for all cases where a detainee has active TB. Given that ICE 
only provides detainee-requested HIV screening, the requirement for HIV screening for 
detainees with active TB could mean (in the absence of available data) that many of the 
HIV cases detected in ICE custody are among those with active TB. This has 
implications if comparing the care transition plans put in place for active TB and 
HIV/AIDS, potentially for the same detainee.  
• The 2011 PBNDS places both active TB and HIV/AIDS in the same category—defining 
them as “medical conditions requiring ongoing therapy.” 
• The 2011 PBNDS classifies HIV, AIDS, Multi-drug resistant (MDR)-TB, and 
extensively-drug resistant (XDR)-TB disease in the same way—as “medical conditions 
that may be considered to constitute serious physical illness.”  
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• Fourth, both active TB screening and HIV/AIDS screening are afforded considerable 
discussion in the 2011 PBNDS and the 2019 NDS. Although they have different 
protocols in place, both are complicated to treat and require special attention from IHSC.   
Also, ample differences exist between the two diseases that led this investigator to explore in the 
discussion section of this dissertation regarding other models for care transition that might better 
inform HIV care transition for returned aliens. For example, TB is time-limited (if treated 
properly), whereas HIV is a chronic condition that requires a lifetime of treatment.  
Significance 
While the political debate about immigration is in the spotlight, the effect of alien 
removals on public health and, in particular, binational continuity of HIV care has received little 
attention. While ICE provides opt-in HIV screening (requested by the detainee) and treatment 
while in ICE custody, a major gap exists in care transition for HIV-infected detainees once 
removed from the United States. Currently, a process does not exist for linking HIV-infected ICE 
detainees with continued HIV care and treatment upon removal from the United States. 
Protecting the health of detained aliens removed to Mexico by ICE can offer positive health 
benefits for both countries, particularly by mitigating the spread of HIV in the aliens’ place of 
arrival, their home in Mexico, and in U.S. communities. However, removal from the United 
States does not mean the alien will never again be a member of a U.S. community. In FY 2018, 
CBP reported that Border Patrol caught 11% of aliens apprehended more than one time within 
the same FY (U.S. CBP, 2019). Given the size, mobility, and binational nature of the deported 
alien population in Mexico, ensuring HIV care transition can not only protect the aliens’ health 
by maintaining viral suppression but lower the risk of transmitting the disease to others as people 




This exploratory research study focused on continuity of care for detained HIV-infected 
aliens removed to Mexico by ICE. The major outcome of the research was to identify feasible 
policy proposal(s) to present to key decision-makers who can address the issue. Many 
policymaking frameworks are available that attempt to explain why and how specific policies get 
adopted. The investigator reviewed six frameworks to winnow it down to three potential 
frameworks—and ultimately one—that informed this research. The three conceptual frameworks 
considered for this study were: 1) Rogers’ diffusion of innovation (DOI) (1962, 2003); 2) 
Ostrom’s institutional analysis and development (IAD) (1990); and 3) Kingdon’s multiple 
streams framework (MSF) (1984, 1995). Table 3 provides comparative information for each.  
Table 3. Comparison of Three Policy Process Conceptual Models 
Conceptual 
Model 
Kingdon’s Multiple Streams 
Framework (1984, 1995) 
Ostrom’s Institutional 
Analysis and Development 
(1990) 
Rogers’s Diffusion of 
Innovation (1962, 2003) 
 
Scope 
Policy Development and 
Choice 




Three “streams” (problems, 
policy, politics) that come 
together during “windows of 
opportunity” to cause major 
policy change 
Conditions that lead to 
collective action and 
principles of governance 
Determinants of policy 




Collective action venue 
(e.g., coalition, network)  
Policymaking venues (e.g., 
legislature) 
Actors Policymakers Primarily individuals 
Policymakers; officials; interest 
groups 
Ideas 
Policy solutions proposed and 
amended over time to become 
acceptable to a policy 
community 
Shared norms of actors 
The norms of policy adoption 
that influence policy borrowers 
Context 
National mood, policy 






religious) that affect how 
people can act and which rules 




The interaction between two 
kinds of ideas: the type of 
policy solution that could draw 
attention and quickly catch on, 
and the established set of 
Considers questions related 
to how rules are crafted and 
how they affect human 
behavior. Issues of policy 
formulation arise under this 
framework as do questions 




beliefs in a policy community 
that would slow its progress. 
about the effects of policy 
design on actors. 
 
DOI focuses on the norms of policy adoption and its diffusion (e.g., from one state to 
another). It explores the conditions, such as socioeconomic or ideological, that affect which 
policies get used and adopted by others. IAD focuses on “collective action” problems, such as 
the provision of health care or the challenges associated with coming to an agreement around a 
set of rules that could benefit a group. IAD offers a roadmap to analyze how institutional choices 
are implemented, but it does not offer a roadmap to design a policy that addresses the collective 
action problem. MSF is a tool for understanding how agenda-setting happens (i.e., how issues 
become prominent on policy agendas). It does not focus on the later stages of the policy process. 
In the framework, three separate streams (problems, policies, and politics) come together during 
a “window of opportunity” to result in public policy. The MSF enables a study of policy 
generation. It also helps to explain why some political issues receive attention while others do 
not. 
To help guide this work, the investigator used Kingdon’s (1984, 1995) MSF as the 
theoretical reference point because the research focused on developing policy recommendations 
to address the research question, presented in Figure 1. Because the IAD framework is most 
helpful to explore institutional policies, it was not a clear match for this exploratory research 
focused on developing policy recommendation(s). Similarly, DOI’s emphasis on policy diffusion 
would be more helpful as a framework once policy is implemented, which was downstream from 
the goal of this research. In MSF, the role of problem definition is important—“how does a given 
condition get defined as a problem for which government action is an appropriate remedy?” 
(Kingdon, 1995). This perspective was congruent with the intended focus explored in this 
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dissertation, later addressed in Chapter 6 (Plan for Change). This is why the investigator selected 
MSF.  
Figure 1. Conceptual Model (Kingdon’s Multiple Streams Framework) 
 
 According to Kingdon (1984, 1995), the development of public policy consists of a series 
of processes including at least (a) setting the agenda; (b) specifying policy alternatives from 
which to choose; (c) making an “authoritative choice” (1995, p. 3) among alternatives by, for 
example, a legislative vote or presidential decision; and (d) implementing the decision. To 
understand these processes of policy formation, Kingdon described three normally separate 
independent streams that are encouraged by individuals, political action committees, and/or other 
organizations and stakeholders (aka policy entrepreneurs) who take advantage of opportunities to 
influence policy outcomes as follows: 
• The problem stream (in which various issues compete for attention and priority on 
policymakers’ agendas). Problems are policy issues, which are deemed to require 
attention. Problems get attention based on how they are framed. In some cases, issues 
receive attention because of a crisis or a change in the scale of the problem. Only a tiny 
fraction of problems receive policymaker attention. Getting attention is a major 
achievement that must be acted upon quickly before attention shifts elsewhere. One 
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action could be to demonstrate that a cheaper, easier, more feasible, and/or politically 
palatable solution already exists. 
• The policy “solution” stream (in which various policy ideas for addressing particular 
problems are floated, tested, discussed, revised, and packaged). Kingdon described ideas 
in a “policy primeval soup,” evolving as they are proposed by one actor then 
reconsidered and modified by a large number of participants. Widely-accepted solutions 
in anticipating future problems are the norm until there is a good time to exploit or 
encourage particular attention to a relevant problem. 
• The political stream (in which key decision-makers in the legislative or executive branch 
propose, debate, enact, or resist specific policy initiatives). In this stream, policymakers 
have to pay attention to the problem and be receptive to the proposed solution. They may 
supplement their own beliefs with their perception of the “national mood” and the 
feedback they receive from interest groups and political parties. In some cases, only a 
change of government may be enough to provide a motive for policymakers to take up a 
proposed policy solution. 
The MSF does not see policymaking as linear; instead, each of the streams exists 
continuously and independently and may become coupled only when a “window of opportunity” 
opens. Because of this, feasible policy solutions can be developed before a problem is 
highlighted, problems are often defined and redefined, and politicians may champion a cause 
before its time has come. The process, at times, appears random, but Kingdon argued that there 
are conditions that structure and constrain it. For example, not all problems have an equal chance 
of getting on the agenda; rather, focusing events propel some forward while others are ignored. 
Additionally, not all policy proposals surface. In the political stream, some groups have more 
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visibility, some policymakers more power. Other constraints include the scarcity of “open 
windows” and the receptivity of the national mood. 
Kingdon’s (1984, 1995) MSF was well suited for this study because the focus of this 
exploratory research was to identify at least one viable policy solution that will be ready for 
action when a “window of opportunity” presents itself. Given the amount of recent news 
coverage about alien movement to and from the United States, it seems probable that the 
“political stream” and “problem stream” will continue to churn while the “policy stream” is 
finalized. It could be that “windows of opportunity” will open over the next few years that will 
afford the possibility for policy adoption to address HIV care transition for aliens removed by 
ICE to Mexico.   
Because the MSF model does not address how the three streams (problems, policy, 
politics) intersect and interact, the discussion section of the dissertation explores the ultimate 
applicability of this chosen framework along with limitations.  
Definitions 
The alien population that this research focuses on are those aliens detained in the interior 
of the United States by ICE. While there are asylum seekers in ICE detention, CBP handles the 
majority of aliens seeking asylum at U.S. ports-of-entry and so are managed in ways external to 
ICE detention. Therefore, this research did not focus on them. The terminology used in this 
research was consistent with that of the U.S. federal government. All terms below came from the 
glossary of U.S. Citizenship and Immigration Services (U.S. USCIS, 2019) unless otherwise 
noted.  
• Alien refers to any person who is not a citizen or national of the United States. 
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• HIV and tuberculosis care transition, for this specific research project, refers to the 
coordination and continuity of health care for HIV—and/or active TB-infected aliens 
removed from immigration detention in the United States to Mexico.  
• Immigration detention is the policy of holding aliens awaiting judicial or legal proceedings 
or repatriate them to their country of departure.  
• Removal occurs when the federal government orders that an alien be expulsed from the 
United States. This expulsion may be based on the grounds of inadmissibility to the United 
States or deportability for a violation of immigration law. ICE removals include both aliens 
arrested by ICE and aliens who were apprehended by CBP and turned over to ICE for 
repatriation efforts.  
• MDR-TB, or multi-drug resistant TB, is a type of TB caused by mycobacterial strains 
showing in vitro resistance to at least isoniazid and rifampicin, the two most potent first-line 
drugs for TB treatment (World Health Organization, 2011).  
• XDR-TB, or extensively drug-resistant TB, is caused by mycobacterial strains showing in 
vitro resistance to isoniazid and rifampicin plus any fluoroquinolone and at least one of the 
injectable second-line drugs: amikacin, capreomycin, or kanamycin (World Health 
Organization, 2011). 
Research Question  
The primary research question was as follows: How can HIV care transition be improved 
when U.S. Immigration and Customs Enforcement repatriates detained aliens to Mexico? The 
research in this dissertation was exploratory, and the goal was to understand how HIV care 
transition can be improved for detained aliens removed by ICE to Mexico. This exploratory 
research addressed three aims: 1) explore the current quality of HIV care transition for detained 
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HIV-infected aliens removed to Mexico by ICE; 2) identify challenges impacting the HIV care 
transition for this population; and 3) explore lessons from tuberculosis care transition that can be 
applied to HIV.  
Research Interests 
The investigator possesses extensive experience and a strong interest in health concerns 
in the U.S.-Mexico Border region. As a former project officer for the U.S.-México Border Health 
Commission (USMBHC), a binational Presidential commission co-chaired by the Secretaries of 
Health of both the United States and Mexico, the investigator gained an appreciation for the 
opportunities and challenges associated with working bi-nationally on infectious disease 
information sharing. The specific question for this dissertation—how to improve HIV care 
transition for HIV-infected aliens removed from the United States to Mexico—was conceived in 
2013 as a result of work conducted during her tenure at the U.S. Department of Health and 
Human Services (HHS) Office of the Secretary. Unfortunately, the investigator was unable to 



















The investigator conducted this research to understand the current quality of HIV care 
transition for HIV-infected aliens removed to Mexico from the United States, challenges 
impacting HIV care transition for this population, and whether lessons exist from TB care 
transition that can be applied to HIV. A systematic search was conducted using the following 
databases: (1) Medline, (2) Embase, (3) PsycInfo, (4) CINAHL, (5) Scopus, and (6) ProQuest 
Central. Medline, Embase, and PsycInfo databases were accessed via Ovid. CINAHL was 
accessed via EBSCO Information Services. The search was restricted to publications in English. 
In addition, bibliographies of retrieved articles were hand-searched. The search terms used are 
described below in Table 4. 
Table 4. Search Terms for Literature Review  
 
Date Limitations: 1996 to the Present 
Concept Key words, search terms 
Detained immigrant Undocumented immigrants/AND (detained OR detention).ti,ab.) OR 
(detain*adj5 (migrant* or immigrant* or refugee* or alien)).ti,ab.OR 
(detention*adj5(migrant* or immigrant* or refugee* or alien)).ti,ab.  
AND 
Health while detained, specifically 
HIV and TB 
Health* OR medical OR HIV OR TB OR tuberculosis 
AND 
Location United States, Mexico  
*Presented for Ovid search, slightly modified for EBSCO Information Services, Scopus, and ProQuest Central 
 
Inclusion and Exclusion Criteria 
Only those studies published since the September 1996 enactment of IIRIRA were 
reviewed. Table 5 details inclusion and exclusion criteria used. 
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Table 5. Inclusion and Exclusion Criteria 
 
Inclusion Criteria Exclusion Criteria 
Be written in English Not written in English 
Be a full-text article Not full-text  
Peer-reviewed publications or high-quality grey literature 
(i.e., includes methods) 
Low-quality grey literature 
Source is original, empirical study designed to measure 
the effect of a policy, practice, or intervention 
Source is not original, empirical work (i.e., 
conference proceedings, abstracts, systematic 
reviews, meta-analyses) 
Published between September 1, 1996 and October 15, 
2018 
Published before September 1, 1996 
Study examines the HIV and/or TB care continuum 
within the immigration detention system in the United 
States and/or upon repatriation to an alien’s home 
country 
Study does not examine the HIV and/or TB care 
continuum within the immigration detention system 
in the United States and/or upon repatriation to an 
alien’s home country 
 
 
The search strategy to integrate these criteria is described below in Figure 2.  
Figure 2. Search Strategy to Integrate Inclusion and Exclusion Criteria 
 
Study Selection 
The eligibility assessment of articles was performed independently in a standardized 
manner by one reviewer. The absence of multiple reviewers was a limitation and area of 
potential bias for this review. All articles identified through the information sources collection 
process were imported into Endnote, a reference manager software, for screening by the reviewer 
based on titles and abstracts. Full-text articles were reviewed and designated whether they met 
Identified database (above) 
searched using the terms from 
Table 1.
All identified manuscripts were 
entered into Endnote and 
duplicates were omitted using 
automated "find duplicates" 
function with preference set to 
match on title, author, and year.
Tier 1 - Reviewed all manuscripts 
at the title/abstract level and 
evaluated against 
inclusion/exclusion criteria from 
Table 2.
Tier 2 - Initial full text review of 
all remaining manuscripts 
confirmed eligibility for this 
analysis. The rationale for 
manuscripts to be excluded based 
on this second tier documented in 
Endnote.
For those manuscripts not subject 
to exclusion following Tier 1 or 
Tier 2, a final full text review 
took place.  Key study parameters 
and conclusions as well as quality 




the inclusion criteria or not. Duplicates were removed automatically from Endnote, but the 
reviewer also looked for duplicates during the review process as well. The articles remaining 
after all exclusion criteria were applied and reviewed in full of key information.  
Results 
The primary search strategy yielded 236 articles from search engines. Articles were 
entered into Endnote and then Covidence for de-duplication. This led to a total of 162 articles. 
The initial title and abstract review excluded 150 articles, leaving 12 eligible for full-text review. 
An additional two articles were identified through bibliographic references. In the full-text 
review, three articles were excluded for the following reason: the study did not examine the HIV 
and/or TB care transition within the immigration detention system in the United States and/or 
upon repatriation to an alien’s home country (n=3). Eleven articles were included in this review, 
as presented in Figure 3.  
 
Figure 3. PRISMA Diagram 
 
 
Rates of HIV Infection among Aliens Detained by ICE and Removed to Mexico 
The effect of removals on public health and the binational care transition has received 
little attention. One reason is the lack of data to assess the extent of the problem (Page et al., 
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2018). Little is known about the prevalence of HIV infection and risk factors among aliens 
removed by ICE to Mexico. Information on immigration status is often unavailable in HIV 
epidemiological studies on Mexican migrants in the United States. Estimates of HIV infection 
and related risk factors among deported Mexican migrants are challenged by methodological 
difficulties to reach representative samples of this highly mobile population in Mexico (Page et 
al., 2018). 
Researchers and practitioners have to use other methodologies to calculate the prevalence 
of HIV in those persons ICE repatriated to Mexico. Rangel et al. (2012) conducted a cross-
sectional survey with deported Mexican migrants in Tijuana, Mexico (N=693) and estimated 
levels of HIV infection in this population. Results indicated a 0.8% prevalence of HIV infection 
among deported males, more than twice that estimated for the adult population in Mexico (0.3%)  
(Joint United Nations Programme on HIV/AIDS [UNAIDS], 2017).  
Barriers for HIV Care Transition for HIV-Infected Aliens Removed to Mexico  
According to Page et al. (2018), maintaining uninterrupted continuity of care among 
aliens held in U.S. detention or removed to their home countries is challenging. Maintaining HIV 
suppression requires intensive case management, access to treatment of mental health and 
substance use disorders, adherence support interventions, and coordination of medical care. None 
of these resources are routinely available to HIV-infected aliens deported from the United States 
(other than a 30-day supply of antiretroviral (ART) if they were receiving therapy while 
detained) (Page et al., 2018). The literature search identified three main barriers for HIV care 
transition: 1) location of repatriation, 2) lack of medical records, and 3) lack of health insurance 
and access to health care among Mexican deportees. 
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Barrier #1: Location of Repatriation. Immigrants are typically released at the border 
between Mexico and the United States without identification, money, food, and shelter, and with 
few personal belongings (Rangel et al., 2012; Truby, 2014). Most find themselves in unfamiliar 
territory, far from their home communities, and for many, their immediate priority is how to re-
enter the United States. Clinics capable of caring for HIV-infected individuals might not be 
easily accessible to those immigrants interested in seeking HIV care because of distance or lack 
of health coverage (Page et al., 2018).  
Barrier #2: Lack of Medical Records. Currently, HIV-infected detained aliens are not 
repatriated with the appropriate documentation to seek treatment in Mexico, such as medical 
records (Truby, 2014). The full list of required documents is presented herein. Mexican providers 
are often uncomfortable prescribing HIV treatment without previous medical records (Aids 
Education and Training Center [AETC], 2018). Nearly all HIV medications available in the 
United States are now available in Mexico (AETC, 2018). With that said, patterns of drug 
resistance circulated in the United States might also differ, and the first-line regimen in Mexico 
might be inadequate for patients with pre-existing resistance mutations (Page et al., 2018). 
Without access to previous medical records (including drug resistance profiles), health care 
providers in the receiving country might have insufficient medical history information on 
patients to make appropriate treatment decisions about removed aliens with drug-resistant HIV 
(AETC, 2018).  
The United States-Mexico Border AETC Steering Team (UMBAST) is sponsored by the 
Health Resources and Services Administration (HRSA) Ryan White HIV/AIDS Program and is a 
collaboration of AETC and the U.S.-Mexico Border States: Arizona, California, New Mexico, 
and Texas. UMBAST has developed fact sheets to assist U.S. providers who have patients 
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leaving the United States for Mexico and Central American countries. The goal of the 
information is to improve continuity of care for migrant patients, including deportees, with HIV. 
According to AETC (2018), Mexican citizens must provide certain documents to be able to 
receive HIV medications in Mexico. The two necessary pieces of documentation are 1) a positive 
HIV antibody test result and 2) a patient CURP number (Mexican federal ID # or the “Clave 
Unica de Registro de Población”). The recommended pieces of documentation are as follows: 
• A recent CD4 + T-cell count. 
• A recent viral load test result. 
• Medical chart copy including complete antiretroviral treatment history. 
Barrier #3: Lack of Health Insurance and Access to Health Care among Mexican 
Deportees. Despite the growing evidence of the health challenges that confront Mexican 
deportees, very little is known about their access to health care upon return (Wassink, 2018). 
Scholars have begun highlighting especially low access to health care among recently returned 
migrants (Martinez-Donate et al., 2017; Wassink, 2018). However, no nationally representative 
studies have investigated access to a regular source of care among Mexican deportees.  
Using data from a recent survey conducted in Tijuana, Mexico, Martinez-Donate et al. 
(2017) found that Mexican migrants (referring to both voluntary and involuntary migrants) have 
significantly lower health coverage and access to care upon return relative to their pre-migration 
levels, indicating that migration may be associated with a lapse in coverage. Wassink (2018) 
investigated return migrants’ health insurance coverage and access to medical care using data 
from the 2009 and 2014 rounds of Mexico’s National Survey of Demographic Dynamics 
(ENADID, combined n=632,678). Results suggest that health insurance coverage is especially 
low among those who returned within the past year, a gap that largely results from lower 
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employment-based coverage among return migrants, who tend to work in the informal sector of 
the economy. For most returned migrants, securing employment represents an immediate and 
pressing concern (Wassink, 2018). Relative to non-migrants, recently returned migrants rely 
disproportionately on private clinics, pharmacies, and self-medication. Moreover, reliance on 
private clinics and pharmacies places return migrants at increased risk of incurring catastrophic 
medical expenses and going without medical care, especially preventive treatment (Wassink, 
2018).  
These findings highlight the need for targeted policies aimed at 1) re-integrating Mexican 
deportees into the labor market, which may have broader benefits for their reintegration into 
important services, such as health care, and 2) ensuring all removed aliens have access to their 
Mexican federal ID number, known as the CURP (Clave Única de Registro de Población). The 
CURP is needed to receive health care under Mexico’s el Instituto Nacional de Salud para el 
Bienestar or the Health Institute for Wellbeing in English, commonly referred to as INSABI. 
This new program, INSABI, replaced Seguro Popular (the People’s Insurance) on January 1, 
2020. Seguro Popular was a universal health insurance program designed to complement 
Mexico’s employment-based social security program. INSABI is designed to provide 
comprehensive coverage for everyone, at any hospital or clinic belonging to Mexico’s public 
health system at no cost to the patient. All medications are covered, including HIV/AIDS 
treatment. Under INSABI, there is no enrollment needed. To access Mexico’s public health 






Key Components of Binational HIV Care Transition 
The literature on disease and borders nearly unanimously promotes binational 
collaboration as a policy objective, focusing on information sharing and disease monitoring 
(Truby, 2014). The literature search identified two main components for successful HIV care 
transition: data-sharing policies and engagement with civil society. 
Component #1: Data-Sharing Policies. Developing legally and ethically sound data-
sharing policies to strengthen the coordination of care transition between the United States and 
Mexico is crucial to ensure binational HIV care transition. These policies are not straightforward 
to implement but models are available that can be instructive, including TB models. Currently, 
ICE does not have an HIV surveillance system (Venters et al., 2009). Methods of data collection 
and identification of detained aliens infected with HIV removed to Mexico (compliant with 
patient autonomy and protection of confidentiality) should be improved (Page et al., 2018). 
Component #2: Engagement with Civil Society. Truby (2014) examined how HIV-
focused civil society organizations operate at Mexico’s northern border. The nature of ICE 
repatriation and of temporary, mobile populations create challenges for addressing HIV/AIDS.  
Many HIV-infected deportees avoid government institutions, making them more likely to avoid 
state assistance, and experience a temporary, unsettled life at the border (Truby, 2014). Hostility 
in the Mexican state and local debates (regarding immigrant access to services) has fueled a 
climate that deters lawfully present immigrants from securing health services (Truby, 2014). It is 
for these reasons that civil society organizations might be better equipped to serve as first-line 
defenses in the fight against HIV/AIDS at the border. However, without sufficient CAPASITy 
and resources, civil society organizations cannot control the epidemic unilaterally.  
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According to Truby (2014), the receiving country should establish initiatives to facilitate 
the reintegration of patients into their health care system, including confidential assistance for all 
HIV-infected aliens removed to Mexico by ICE should be provided immediately upon their 
return. According to Page et al. (2018), the establishment of these focused initiatives is essential 
for linking deportees to health and social programs in Mexico to which they might be entitled. 
Local collaborative partnerships between the Mexican government, community-based 
organizations, public health departments, and investigators on both sides of the border have been 
developed to provide access to basic medical services and HIV prevention resources to 
deportees. Rangel et al. (2012) identified that what these programs do not include are initiatives 
to increase the availability of financial, social, and emotional support for recent deportees as they 
are released in the U.S.-Mexico border region. 
Coordinating Care Transition for TB-Infected Aliens Removed to Mexico 
TB patients crossing national borders face an array of challenges in cross-border TB 
control. These include limited access to early TB diagnosis, a lack of continuity of care for TB 
patients when they move to another country, and no or little information to the health providers 
in the countries of transit, destination, and return (Schneider & Lobato, 2007). Often a lack of 
appropriate and/or adequate information exists for patients as to their rights, availability of health 
services, coverage entitlements, and accessibility of services. In some countries, there is no 
provision for the coverage of TB diagnosis and treatment costs, which mainly rely on individual 
payment. These are further complicated by cultural and language barriers and stigma. 
Although there are programs and pilots aimed at creating a framework for cross-border 
collaboration for TB care transition, academic publications on the topic are scant. Two national 
working groups, convened by CDC, have published reports that address the public health 
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importance of the continuity of TB therapy for TB-infected aliens in ICE custody (Schneider & 
Lobato, 2007). A governmental ad-hoc working group was established in 2002 to address 
concerns regarding detained TB-infected aliens who experience interruption of TB therapy when 
removed to Mexico by ICE (Fenton & Castro, 2006). With guidance from this working group, 
ICE established policies and procedures for collaborating with TB control programs, foreign 
national TB programs, and programs that facilitate international TB referrals, continuity of care, 
and treatment completion. Through these collaborations, ICE detainees with confirmed or 
suspected TB disease are routinely enrolled in CureTB (San Diego County Health Department, 
San Diego, CA), and TB Net (Migrant Clinicians Network, Austin, TX). 
Dara et al. (2012) described the minimum package of cross-border TB control and care 
elements to address the issues identified herein. The resulting consensus document outlines four 
components to address the current shortcomings and enhance the coordination of transnational 
continuity of care for patients with TB, presented in Table 6. Consensus was reached to indicate 
that three working days’ notice comprised the maximum time necessary to share information on 











Table 6. The Minimum Package for Cross-Border TB Control and Care  
 
Element Components Considerations 




• Commitment to cross-border control and care; ensure 
legal basis 
• Ensure funding from government resources, health 
insurance, and/or bilateral and multilateral funding 
(treatment should not be at cost to the patient) 
• Create a list of live TB service providers to be maintained 
by a “reference center” in each country specifically 




• TB infection control 
• Diagnosis 
• Treatment 
• Continuity of care 
• Diagnose and treat latent TB infection, irrespective of 
patients’ legal status (note: ensure treatment of drug-
resistant TB and TB/HIV co-infection) 
• Pursue early diagnosis 
• Provide prompt and effective treatment 
• Do not deport before the end of treatment, or at least until 
the end of intensive phase, and ensure continuation phase 




• Individual patient data 
• Program performance 
• Effectively transfer patient’s medical record 
• Provide sufficient TB medications to ensure treatment 
until the patient’s care is resumed 
• Provide feedback to the center sending the patients 
• Collect data for indicators at the country and regional 
level to measure progress (example indicators include: # 
of TB patients diagnosed as having TB before moving to 
another country, # of TB patients who crossed the border 
and successfully completed treatment) 
Supportive 
environment 
• Enablers and incentives 
• Advocacy communication 
and social mobilization 
• Provide counseling and psychosocial support to patients 
• Empower communities to provide migrant-sensitive 
services 
• Improve communication with civil society, migrant 
communities 
• Advocate for full engagement of health authorities and 
stakeholders 
• Ensure cross-border monitoring mechanisms are in place 
Source: (Dara et al., 2012) 
 
Schneider and Lobato (2007) reviewed TB cases reported for ICE detainees from 2004-
2005. They found that during 2004 and 2005, 76 and 142 TB patients were reported, 
respectively. Detainees from Mexico and Central America accounted for 84.4% (184) of the 
cases. TB-infected detainees spent an average of 82.6 days in treatment before release or 
repatriation back to their home country of record. The study concluded that because detained, 
active TB-infected aliens are usually deported before completing TB therapy, and sometimes re-
enter the United States, unique collaborations are required to support completion of treatment.   
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Tschampl et al. (2016) estimated the proportion of removed aliens who received 
transnational TB care–continuity services by using case management data from the two-provider 
organizations. Approximately 10% of removed aliens received transnational continuity of TB 
care services. Thus, ~90% of TB-infected aliens departed the United States without such 
services, a finding that highlights a neglected public health area and the feasibility of scaling up 
intervention. A related and somewhat encouraging finding was that 67% (124/186) of TB-
infected aliens receiving transnational services were among those detained before removal. 
Assuring all who are removed receive transnational services is another way to avoid treatment 
interruption and development of drug-resistant TB. 
One Mexican Program in Place to Address Binational AIDS Care Transition 
Mexico’s Outpatient AIDS Clinics (CAPASITS, the Spanish acronym which stands 
for “Centro Ambulatorio de Prevención y Atención en SIDA e ITS”). The CAPASITS 
network was introduced in Mexico in 2005 and is still expanding (AETC, 2018; Truby, 2014). 
As of 2016, it comprised 76 centers around the country (AETC, 2018). The Mexican federal 
agency in charge of HIV treatment and prevention, CENSIDA, operates a national toll-free 
hotline for people, including deportees, to call when they are in Mexico to find the closest care 
provider. All HIV-positive patients can be seen at CAPASITS for three months without a 
Mexican federal ID number (CURP). 
Discussion 
Binational HIV care transition is complex. Creating a robust public health approach to 
facilitate HIV care transition among detained aliens removed to Mexico by ICE will require 
political will and financial commitment from the United States and from Mexico. The literature 
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results highlighted several key components of the continuity of HIV care that must be put in 
place. 
Within ICE facilities, methods of data collection and identification of detained aliens 
infected with HIV (compliant with patient autonomy and protection of confidentiality) should be 
improved to monitor care transition for deportees. Developing legally sound data-sharing 
policies that strengthen the coordination of linkage to care between both countries is crucial to 
ensure the continuity of HIV care across the shared border. These policy changes are not 
straightforward to implement, but there are TB models available that can be instructive.  
The consensus document (Dara et al., 2012) outlining recommendations for coordinating 
transnational continuity of patient care with TB highlights key elements, including political 
commitment (e.g., a legal framework for cross-border collaboration), adequate governance and 
financial mechanisms, surveillance and monitoring, and adequate health service delivery. In the 
United States, TB Net coordinates continuity of care for migrant populations and has facilitated 
care coordination for over 1,500 migrants from the United States with active TB (Page et al., 
2018). The Network provides a HIPAA-compliant platform to share medical records with 
international providers and link patients to care through virtual case management. CDC 
cooperates with ICE to coordinate care for active TB cases across borders.  
 On the receiving end, Mexico needs to enhance initiatives to facilitate the reintegration of 
deportees into its health care system. The literature review revealed limited access to medical 
care among recently returned migrants (Martinez-Donate et al., 2017; Wassink, 2018). 
Assistance for all HIV-infected deportees immediately upon their return is essential to link them 
to health and social programs to which they might be entitled. A need exists for targeted policies 
to facilitate successful reintegration and ensure access to vital resources such as health care. 
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Mexico’s civil society organizations might be best equipped to engage with recent deportees and 
link them to care (Truby, 2014).   
 Although the literature stresses the need to increase HIV testing and treatment in border 
communities, the transitory existence of the deportees makes treatment and adherence difficult 
(Truby, 2014). Continuation of both HIV and TB care between countries should occur through a 
shared updated list of HIV and TB services and national focal points for effective and timely 
communication regarding transferred active TB cases. 
The literature review presented clear challenges for HIV care transition, areas for 
opportunity, and examples to examine further. The adaptation of the TB framework presented in 










CHAPTER 3: METHODOLOGY  
 
 
Study Design and Methods 
 
This dissertation included both a qualitative and a quantitative study to address the 
following research question: How can HIV care transition be improved when U.S. Immigration 
and Customs Enforcement repatriates detained aliens to Mexico? An exploratory convergent 
mixed-methods design was employed, presented in Figure 4. Mixed methods research is “an 
approach to inquiry involving collecting both quantitative and qualitative data, integrating the 
two forms of data, and using distinct designs that may involve philosophical assumptions and 
theoretical frameworks” (Creswell & Creswell, 2018). A convergent mixed-methods design 
means that data collection occurred simultaneously but separately.  




Described herein are the aims and corresponding associated data collection methods of 
this study, arrived at under close guidance of the investigator’s dissertation chair as follows:  
• AIM 1: Explore how various stakeholders perceive the current quality of HIV care 
transition for detained, HIV-infected aliens removed from the United States to Mexico 
o Method: Literature review; key informant interviews. 
• AIM 2: Identify some of the challenges affecting HIV care transition for detained, HIV-
infected aliens removed from the United States to Mexico 
o Method: Literature review; secondary analysis of quantitative data; key informant 
interviews. 
• AIM 3: Explore whether there are lessons from TB care transition (or other models) for 
detained, TB-infected aliens removed from the United States to Mexico that can be 
applied to HIV care transition. 
o Method: Literature review; secondary analysis of quantitative data; key informant 
interviews. 
• AIM 4: Develop a plan for change (i.e., policy agenda) that will improve HIV care 
transition for detained, HIV-infected aliens removed from the United States to Mexico   
o Method: Synthesize results from aims #1-3. 
One aim was not pursued because data were not available to explore the impact of challenges 
affecting HIV care transition have on HIV treatment adherence following the ICE removal of 
HIV-infected aliens to Mexico. 
Institutional Review Board and Confidentiality 
The proposal was reviewed and approved by the University of North Carolina (UNC), 
Chapel Hill Institutional Review Board (IRB). The investigator began collecting data and 
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conducting analyses for the key informant interviews upon approval of the UNC IRB. In 
addition, the investigator, currently employed by the Centers for Disease Control and Prevention 
(CDC), collected data as a graduate student at UNC Chapel Hill and not on behalf of the federal 
government (data collection was not federally-sponsored). Therefore, CDC leadership stated 
their reliance on the UNC IRB for review and approval of this study.   
 Sources of Material 
Primary data for this study was obtained through individual key informant interviews 
conducted between October 1, 2019, and January 15, 2020. Secondary data (de-identified) was 
obtained through the Texas Department of State Health Services’ annual HIV Surveillance 
Report for 2018, the latest year data are available, which is publicly available (Texas Department 
of State Health Services, 2019).   
Informed Consent 
Informed consent was obtained verbally and recorded. With each key informant 
interview, I shared the consent form ahead of time and received verbal approval of consent from 
the interviewee at the beginning of the recording. Assurances of confidentiality were maintained 
throughout the study. The consent form used is available in Appendix C.  
Potential Risks and Protection against Risk 
The primary risk to key informant interview participants was a breach of confidentiality. 
To minimize this risk, interviewees were not connected to their answers in any way. Each 
interviewee was issued an ID number that was used for the interview, rather than their name. 
Their name will not be used in any study report, final report, or publications. Once the data were 
compiled, all identifying information associated with their answers was removed.  
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Audio recordings of the key informant interviews were transcribed; names and other 
identifiers were not included in the transcribed copies. Electronic copies of transcriptions were 
stored on password-protected computers on a secure server. Keys linking names and personally 
identifiable information with ID numbers were destroyed once the database was complete and 
ready for analysis. All data was on password-protected servers until the study results were 
completed. All field notes were kept in a locked cabinet in the principal investigator’s office. 
Access to print and electronic files was restricted to the study investigators. When the study 
results were completed, the electronic and paper data were destroyed. 
Methodology: Quantitative Study  
To identify challenges and inform recommendations to strengthen care transition for 
detained HIV-infected aliens removed to Mexico from the United States and explore lessons 
learned from TB care transition that can impact HIV care transition, current (baseline) 
descriptive statistics are needed, such as the prevalence of HIV in the population of detained and 
removed aliens to Mexico. The most straightforward method to attain these data was to use 
secondary data reported in the literature.  
Because no available data sources exist on HIV prevalence in the population of detained 
and removed aliens to Mexico, the prevalence in this population was calculated using the Texas 
Department of State Health Services annual HIV Surveillance Report that is publicly available 
and includes de-identified annual data for the years 2009 to 2018 (Texas Department of State 
Health Services, 2019). HIV is a notifiable condition in Texas, and ICE officials are obligated to 
report it to the county of which the facility is located. The report does not separate case counts by 
gender, race, or ethnicity.  
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In FY18, 32% of all aliens in ICE detention (ICE, 2019) were geographically located 
within the state of Texas. Using the Texas data, the investigator estimated the prevalence of HIV 
in ICE facilities in FY 2018, the most recent year of available HIV diagnoses on record. This 
data were extrapolated from the entire United States. 
Methodology: Qualitative Study  
  The descriptive statistics were supplemented with primary qualitative data obtained from 
nine key informant interviews of identified stakeholders (see Appendix B for the key informant 
interview guide). These interviews helped inform policy interventions discussed in Chapter 5 
(Policy Analysis) and Chapter 6 (Plan for Change). Key informant questions explored problem 
and policy factors, areas of opportunity, and the role(s) of key decision-makers. 
The investigator started with a list of key informants. During the interview process, they 
were asked if others should be included. Selection of the first five interviewees was based on 
personal knowledge of their high level of experience with immigration detention in the United 
States and/or with HIV and/or TB care transition for detained aliens removed to Mexico by ICE. 
After these sessions, the investigator asked each of them to recommend one to two other people 
who may be interested in participating or have unique perspectives. Interviewees were contacted 
via e-mail with a standardized introduction describing the purpose of the research, expectations 
for the interview, and mechanisms for ensuring the confidentiality of responses. The e-mail 
explained that they were not obligated to participate in the interview and that declining would 
have no effect on professional relationships. A second e-mail followed one week after the first to 
those for whom no response was received. For those with no established contact, an alternate 
interviewee was identified through the participants’ network.  
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Key informant interviews were conducted by telephone. Telephone interviews were 
preferred rather than in-person encounters with professional key informants since professionals 
were likely to have demanding schedules with limited flexibility. The telephone interview was 
recorded (after consent was provided) to allow the interviewer the ability to focus on the 
responses and the informant and not on note-taking. Recorded responses were subsequently 
transcribed for data extraction. Each key informant interview took no longer than 35 minutes to 
complete; however, the interviewer allotted 45 to 60 minutes per key informant to allow the 
informant the opportunity to elaborate when responding to questions. The interviewer opened the 
call by sharing the purpose of the interview and the details of the study.  
Ensuring confidentiality/anonymity is very important. To maintain confidentiality, each 
interviewee received a random numeric identifier, so their specific comments cannot be linked to 
the data. The key informants were informed that their name and title would not be used in the 
final report or publications and that their responses would be kept confidential—results focused 
on the content of the discussion rather than identifying who said what. This helped encourage 
them to participate and make them more willing to share their opinions about the topic openly. 
The information obtained from the key informant interviews was qualitative. The analysis 
of the interviews focused on groupings of themes, a discussion of findings, and a presentation of 
conclusions. The following data analysis steps were taken with the interview recordings and 
transcriptions to identify themes, to compare and contrast responses across interviews, and to 
ultimately assess the themes emerging from the key informant interviews. 
Step 1: Close Reading of the Data 
The responses were read and re-read to gain a deeper understanding of them. The first 
opportunity to examine the data was through transcribing the responses. Once the data were 
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transcribed, the responses were reviewed a second time to reveal nuances not evident from the 
initial transcription. 
Step 2: Identifying Initial Codes 
Codes were assigned to segments of the responses related to the research question to 
begin understanding themes extracted from the key informant interviews. (Note: A code was 
tagged to a word, a phrase, a sentence, or some larger segment of text.) QSR NVivo was used for 
the coding analysis. The coded data was automatically tagged to the source and placed in a file.  
Step 3: Developing Themes 
All the codes were reviewed to determine how different codes might combine to form an 
overarching theme and subthemes. After the first-round of theme development, the themes were 
reviewed for refinement; some themes were collapsed, and others needed to be broken into 
subthemes. The target was for external heterogeneity—distinct themes that represent the dataset 
with clear relationships among the themes and a clear connection to the research question. 
Step 4: Drawing a Thematic Map 
After developing the themes, a thematic map was drawn, visually describing the patterns 
and the relationships among them. The research question lies at the center of the map with 
themes and subthemes connected to it—and showing the relationships between the themes. 
Step 5: Writing the Analysis 
The themes from the key informant interviews were coupled with the descriptive 
statistics from the quantitative analysis, seeing if the merged results produced a clearer 








CHAPTER 4: RESULTS AND DISCUSSION  
 
 
This chapter begins by describing the findings from the convergent mixed methods study: 
1) secondary data from the published literature on the prevalence of HIV in the population of 
detained and removed aliens to Mexico and 2) key informant interviews with stakeholders 
presented by the three research aims. This chapter continues with a discussion on how the 
analysis ties back to the primary research question. Table 7 describes the four research aims and 
associated data and methods of the study. The chapter concludes with an overview of the 
limitations of this exploratory study and recommendations for further research. Chapter 5 (policy 
analysis) and Chapter 6 (plan for change) focus on the fourth and final aim which is to use the 
results in this chapter and develop a plan for change (i.e., policy agenda) that will improve HIV 
care transition for detained HIV-infected aliens removed from the United States to Mexico. 
Table 7. Description of the Study’s Four Research Aims and Supporting Methodology 
Primary research question: How can HIV care transition be improved when U.S. Immigration and Customs 
Enforcement repatriates detained aliens to Mexico? 
Aim Method 
AIM #1: Explore how various stakeholders perceive the current quality of HIV 
care transition for detained, HIV-infected aliens  
-key informant interviews 
-literature review 
AIM #2: Identify some of the challenges affecting HIV care transition for 
detained, HIV-infected aliens removed from the United States to Mexico 
-secondary data analysis  
-key informant interviews 
-literature review 
AIM #3: Explore whether there are lessons from tuberculosis care transition 
(or other models) for detained, TB-infected aliens removed from the United 
States to Mexico that can be applied to HIV care transition 
 
-secondary data analysis  
-key informant interviews 
-literature review 
 









Because no available data sources exist on HIV prevalence in the population of detained 
and removed aliens to Mexico, the prevalence in this population was calculated using the Texas 
Department of State Health Services’ annual HIV Surveillance Report ,which is publicly 
available and includes de-identified annual data for the years 2009 to 2018 (Texas Department of 
State Health Services, 2019). HIV is a notifiable condition in Texas, and ICE officials are 
obligated to report it to the county of which the facility is located. The surveillance report 
includes annual diagnoses of HIV (regardless of disease status, HIV-only or AIDS) in ICE 
facilities with data presented in Figure 5. Data presented do not separate case counts by gender, 
race, or ethnicity.  
Figure 5. Annual Diagnoses of HIV Regardless of Disease Status (HIV-only or AIDS) in 




According to federal government data, in FY18, Texas (15,852), California (6,527), 
Arizona (3,869), Georgia (3,717), and Louisiana (3,143) were the top five states with the largest 
number of aliens in U.S. immigration detention per day (ICE, 2019). In FY18, Texas housed 
32% of all aliens in ICE detention (ICE, 2019). Texas has more detention facilities and holds 
more detained aliens than any other U.S. state. There are a few reasons for the high concentration 






































with Mexico of any state in the United States) and the existence of infrastructure located in 
jurisdictions open to contracting with ICE.  
In FY 2018, ICE facilities performed 179,941 comprehensive health assessments across 
all of its facilities in the ICE detention system in the United States (ICE, 2019). Because 
cumulative figures for a total number of ICE detainees are not available by fiscal year (ICE 
presents data as the number of beds used each day), comprehensive health assessments are an 
approximate measure for the number of new detainees each fiscal year. In FY 2018, ICE 
facilities in Texas reported 31 diagnoses of HIV regardless of disease status (HIV-only or AIDS) 
(ICE, 2018). In FY 2018, ICE reported that 64.4% of detainees were Mexican aliens (ICE, 
2018). Using this information, the investigator estimated the number of HIV diagnoses for all 
ICE detainees in the United States in FY 2018 as follows: 
• (1/0.32 (percentage of ICE detainees in Texas) x 31 (HIV/AIDS diagnoses in Texas 
ICE facilities) = 97 detainees diagnosed with HIV in FY 2018 out of 179,941 
• Given that 65.4% of ICE detainees in FY 2018 were Mexican aliens, the estimated 
number of Mexican detainees diagnosed with HIV in FY 2018 is 0.644*97 = 63 (an 
estimated 63 HIV-infected Mexican aliens are diagnosed with HIV in ICE detention 
each year) 
Using this estimate for the number of Mexican detainees diagnosed with HIV/AIDS in FY 2018 
(63), the investigator was able to estimate the number of HIV-infected aliens repatriated to 
Mexico by ICE in FY 2018 as follows: 
• 0.32 (% of detainees housed in Texas) * 179,941 (health assessments were 




• The FY 2018 HIV prevalence among Texas detainees is 31 (detainees diagnosed 
with HIV in ICE facilities in Texas) / 57,581 = 0.000538 (or 5.38 x 10,000).   
• Using this prevalence (0.000538) and multiplying it against the total number 
repatriated to Mexico in FY 2018 (141,045) = 75 detainees (an estimated 75 HIV-
infected aliens repatriated by ICE to Mexico each year). 
The methodology to calculate the HIV prevalence estimates for detained and repatriated 
Mexican aliens entailed several assumptions and limitations. The first assumption was the 
estimates for the total number of ICE detainees in FY 2018 diagnosed with HIV and detained 
Mexican aliens diagnosed with HIV were low and most likely an underestimate of the actual 
prevalence of HIV/ in ICE detention. This assumption was because HIV screening is at the 
request of the detainee (opt-in), and ICE does not screen for HIV/AIDS (unless an alien has 
active TB). The second assumption was that although Texas is the U.S. state with the largest ICE 
detainee population (32%), it is not the only state with ICE detainees, and, therefore, may not be 
a truly representative sample. The third assumption was that the HIV prevalence in FY 2018 
could be representative of the prevalence in other fiscal years. The fourth assumption was that 
the rate of health assessments that involve an HIV test is the same in Texas compared with other 
states. The fifth assumption was that the likelihood of getting a health assessment among Texas 
detainees is the same for all detainees. The sixth assumption was that the prevalence of HIV 
among Mexican detainees in Texas is roughly the same for all Mexican detainees that may not be 
the case (e.g., it may be that Mexican detainees in Texas are more likely to come from a certain 
state in Mexico that has a higher or lower HIV prevalence than other Mexican states). Lastly, it 
was unclear how many of the aliens diagnosed with HIV have already been receiving HIV 
treatment within the Mexican health care system and, consequently, may not need HIV care 
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transition support to the degree that the other HIV-infected Mexican aliens repatriated to Mexico 
will. However, this estimate of 75 HIV-infected detained aliens repatriated to Mexico each year 
is useful for understanding the demand on ICE regarding care transition of detainees repatriated 
to Mexico. It averages to 2-3 repatriations of HIV-infected Mexican aliens every two weeks.  
Qualitative Study 
This section reports the results of telephone interviews conducted with nine key 
informants, as shown in Table 8. The interviews lasted between 17 and 55 minutes (averaging 32 
minutes). The key informants possessed an average of 15 years of experience working on aspects 
of HIV and/or TB care transition between the United States and Mexico (range 8-35 years).  
Table 8. Sector and Frequency of the Nine Key Informants 
Sector Frequency 
Academia 1 
Local health department (county, regional) 2 
Non-governmental organizations  2 
Clinical practice 2 
State health department  2 
 
This qualitative study used a convenience sample limited to nine key informants. In total, 
17 individuals were approached to participate as key informants in this study. All key informants 
were U.S.-based. Of the eight individuals who were approached but did not participate, two did 
not respond; two were not available to participate in the timeframe requested; three declined to 
participate citing a lack of expertise in the topics to be covered in the interview; and one declined 
to participate for other reasons. The U.S. and Mexican federal government perspectives were not 
represented. Due to the small number of key informants, the results were not generalizable, they 
were exploratory and limited to the experienced and perceptions of those interviewed. It is 
possible that due to the limit of key informants, some viewpoints were inadvertently omitted. 
The content of each key informant interview transcript was coded using NVivo. A priori 
codes were created based on the interview questions—organized by the research aim. Themes 
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are the outcomes of the coding process, as described in Chapter 3 (Methods), and are defined as 
the suggested solutions to the research question of how to improve HIV care transition for 
detained aliens repatriated to Mexico by ICE. Concept tables were used to outline the 
relationship between the research question and research aims, with primary and sub-themes from 
the key informant interviews (see Tables 10-12). The results were organized by the three 
research aims, or questions, and then within each research question, by suggestions for 
improvement (i.e., theme). For each theme, vignettes from the individual interviews were 
included as they supported the key themes and resulting conclusions. A total of seven themes 
emerged from the coding process and are described herein, and presented in Table 9, as “areas 
for improvement” in the HIV care transition process for repatriated Mexican aliens. A summary 
of the suggestions from key informants is also included in Table 9 and organized by theme.  
Table 9. Areas for Improvement (Themes) and Summaries of Suggestions from Key 
Informant Interviews 
 
Areas for Improvement (Themes) 
 
Summary of Suggestions from Informants 
 
Access to HIV services in Mexico Ensure repatriated HIV-infected aliens can access HIV health services 
in Mexico by ensuring they have a federal identification number and 
addressing how to travel to/from health services  
Coordination between ICE and U.S. 
and Mexican health authorities for the 
repatriation of HIV-infected aliens 
Ensure U.S. and Mexican health authorities are included in the removal 
of HIV-infected aliens in ICE custody; the health authorities have 
processes to provide detainees HIV care transition 
Binational exchange of HIV medical 
records 
Address three challenges for U.S.-Mexico HIV medical record sharing: 
access, confidentiality, and patient consent  
ICE procedures for HIV care 
transition 
Educate ICE clinicians on how to connect HIV-infected aliens to care 
in Mexico  
Education of HIV-infected aliens in 
ICE detention  
Educate HIV-infected detainees in ICE facilities on the importance of 
continuing care and treatment and how to access HIV care services in 
Mexico 
Binational agreement(s) for the 
exchange of data and medical records 
Establish data and medical record sharing agreement(s) and ensure that 
the appropriate levels of government (local, state, and federal) from the 
United States and Mexico are informing and driving their development 
ICE detention standard for HIV care 
transition 
Implement ICE’s detention standard for HIV care transition for 
removed aliens (i.e., provide HIV/AIDS medication, referrals to 
providers, and a medical care summary) 
 
Qualitative Results for Aim #1 
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To answer aim #1, key informants were asked two questions about the current situation 
for HIV care transition of detained aliens with responses, presented in Table 10. Two themes 
emerged from their responses: 1) access to HIV services in Mexico and 2) binational 
coordination during repatriation, explored in more detail herein.  
Table 10. Qualitative Results for Research Aim #1 
Aim #1: Explore how various stakeholders perceive the current quality of HIV care transition for detained, HIV-
infected aliens removed from the United States to Mexico. 
Interview questions:  
• How would you describe the current situation regarding the access detained HIV-infected aliens have to 
continued HIV care and treatment in Mexico upon arrival?  
























































Availability and accessibility 
of HIV health services in 
Mexico 
 
All Mexican citizens have a 
right to health care, including 
access to HIV/AIDS 




To access Mexico’s public 
health system, the Mexican 
federal ID #, the CURP (Clave 
Única de Registro de 
Población), is needed 
 
 
Through the CAPASITS, 
HIV/AIDS treatment is 
available; the medications 
provided are on par with those 
available in the United States 
 
A logistical challenge for 
HIV-infected repatriated 




“The Secretaria de Salud operates an HIV program 
known as CAPASITS. Most of the major 
municipalities in Mexico along the border have these 
CAPASITS. So, if a person ends up on the Mexican 
side and they're HIV-positive and under treatment, 
they can go to the CAPASITS and receive their care, 
at no cost.” 
“As soon as somebody is deported through the port-
of-entry, they have to pass through Mexican 
immigration. So, at that point, they must prove their 
Mexican citizenship, and then once they're in Mexico 
they don't have to show a card or anything when they 
go to the CAPASITS. Their federal ID number is 
already in the system.” 
“Access to resources regarding HIV and AIDS 
treatment is being facilitated by the Mexican 
government through the CAPASITS. So, Mexican 
doctors have resources, they have medications, and 
they feel confident when receiving cases. Nearly all 
HIV medications available in the United States are 
now available to in Mexico.” 
“How do you even get to a CAPASITS when you’re 
deported? Accessing the health care in Mexico is a 











U.S. and Mexican health 
authorities have processes 
for HIV care transition for 
detainees—if they are 




“When we know that we have somebody who's HIV-
positive, then the coordination of care is very high. 
We have systems in place with our Mexican health 
counterparts that can be used to facilitate a proper 
medical handover to Mexican health authorities, we 
just need to be notified and included in the removal 
process by ICE.” 
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Emerging Theme #1: Access to HIV Services in Mexico 
 
 Key informants spoke about Mexico’s national policy on HIV treatment that has been 
providing universal access to ART through the national health system since 2003 (UNAIDS, 
2017). According to the national policy, all Mexican citizens have a right to health care. To 
access HIV care, the repatriated alien will need to be in the Mexican immigration system and/or 
otherwise have access to their CURP number, which is their federal ID number. Through the 
CAPASITS, HIV/AIDS treatment is available and on par with those available in the United 
States. The challenge facing repatriated HIV-infected aliens is how to physically access the 
CAPASITS as reported by one physician during the interview:  
So, what we encounter nowadays is that, for example, immigrants come to the U.S.-
Mexico border, they apply for a [U.S.] visa, and they get their medical exam done. And if 
they admit that they have HIV we are supposed to collect smears and cultures for 
tuberculosis. And they must wait in Mexico for at least eight weeks, which is how long it 
takes to find out if the tuberculosis culture is negative. So, they encounter a lot of 
problems because they do not arrive with enough HIV medication for eight weeks and so 
we need to refer them to the health centers, CAPASITS, in Mexico. So that's why I know 
that HIV treatment is available because it is not difficult for me to call a health center and 
tell them like, “Hey, we have an HIV patient and he's going to be traveling through your 
jurisdiction to ask for HIV treatment.” And they will usually get the medicine. So, the 
access is easy.   
 
 For repatriated HIV-infected Mexican aliens, HIV/AIDS treatment is readily available. 
The challenge is in accessing the physical CAPASIT location. If the repatriated alien is not met 
at the port-of-entry by a health official, it is hard to know where CAPASITS are located or how 
to get to one without money. This observation was expressed by one non-government 
organization (NGO) official as follows:  
I know there is a national number that HIV-infected deportees can call to find the closest 
provider. It’s run by the Mexican federal agency in charge of HIV treatment and 
prevention. But this is an inherent challenge as, uh, if you are deported to Mexico and 
have nothing, how will you make this call? Ideally, the linkage to the treatment facility 




Emerging Theme #2: Binational Coordination during Repatriation 
 Key informants spoke about how U.S. and Mexican health authorities have processes in 
place that they can use for HIV care transition for detainees—provided the health authorities 
from the United States and Mexico are included by ICE in the removal process. The missing link 
reported by the key informants was for county and/or state health officials to be notified by ICE 
(by telephone or e-mail) with enough advance notice to arrange care transition with Mexican 
health officials. The U.S. state or county health officials would provide information to the 
Mexican health authorities about the HIV-infected Mexican alien and link them directly with the 
alien during ICE removal. The onus appears to not be on ICE to arrange the care transition, the 
U.S. state and local health departments will do that. What is needed is for ICE to provide that 
advance notification as noted by one state official as follows:  
Having authorities involved at both sides of the border is very effective. For example, the 
person in charge of the health program or the HIV program in El Paso, Texas, for 
example, has the ability to communicate with the head of the HIV program in Juarez, 
Mexico. So just, I mean...by having a good coordination they might, you know, alert the 
person in charge in Mexico like, “There's going to be a patient returning to Mexico 
through this boarder location and he's under this medication. He has been diagnosed on 
this date,” all the clinical information. So, the actual head of the Mexican HIV program 
can receive that patient and then just continue the treatment where it was left. So that's 
something that I would consider successful, bringing all the stakeholders involved on 
HIV care together and work in that same effort.  
 
Qualitative Results for Research Aim #2 
To answer aim #2, key informants were asked three questions about the current 
coordination and cooperation for HIV care transition of detained aliens as well as main 
challenges and administrative barriers. Three themes emerged from their responses: 1) binational 
exchange of medical records, 2) ICE procedures for HIV care transition, and 3) educating HIV-
infected aliens in ICE detention before removal. The investigator explored these three emerging 
themes in more detail, as shown in Table 11.  
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Table 11. Qualitative Results for Research Aim #2 
Aim #2: Identify some of the challenges affecting HIV care transition for detained, HIV-infected aliens 
removed from the United States to Mexico 
Interview questions: 
• How would you characterize the coordination of HIV care transition between U.S. and Mexican 
authorities? How could this cooperation be improved?  
• What are the most important administrative barriers for HIV-infected aliens to access HIV care and 
treatment in Mexico?  
• What are the main challenges for continuity of HIV care and treatment in this population? 
Emerging 
Themes 































Patient consent  
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binational HIV clinical 
record sharing include 
access, confidentiality, 
and patient consent 
concerns 
 
A challenge for timely 
HIV care transition is 
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securely sharing HIV 
patient records between 
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ICE requires patient 
consent to release medical 
records, any delays in 
getting consent impact the 
timely sharing of clinical 
information with Mexican 








“Those who are deported don’t have their 
medical records, but the clinician in Mexico 
needs it to continue the correct treatment. We 
need to figure out a way to get the medical 




“One huge barrier that I see on communication is 
HIPAA compliance. In the U.S. it’s very strict, 
but we don’t use it in Mexico. Sharing a person’s 
sensitive health information through encrypted e-
mails is not accessible for Mexican clinicians, 
either because their computer system doesn't 




“When people bring up patient privacy concerns 
and consent to release, I say, ‘Well, to me that 
would be fairly easily resolved.’ You know the 
person's in ICE custody, and it should be one of 
the forms that they should be signing before 
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U.S. and Mexican health 


































Advance notification from 
ICE to U.S. health 
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with Mexican health 
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Importance of training 
ICE clinicians about why 
connecting patients to 
care in Mexico is 
important and process(es) 
to do so 
 
“No uniform system exists to inform state and 
local HIV programs when a person under ICE 
care who has HIV is going to be deported or 
released. But repatriation should not take place 
until the necessary arrangements with the 






“The primary mission of ICE is law enforcement, 
and the public health side is like the ugly 
stepchild. We mainly see this with complicated 
cases, where we're hoping that ICE could hold 
onto somebody long enough for us to get the 
infrastructure in place on the Mexican side to do 
the care transition. And there’s pushback 
because, from the law enforcement side, they’re 
wanting to remove the person. So, what we need 
to do is spend the time to educate ICE staff about 















Need for routine 
education of HIV-
positive detainees in ICE 
facilities on the 
importance of 
continuing care and 
treatment and where to 
access services 
“With diseases such as HIV—80% of the success 
of the outcome is on the patient and 20% is on the 
clinician. If I were deported, for me to know, 
number one, that a CAPASITS exists, and then, 
how do I get there if I don't have any money in my 
pocket. And so, an administrative barrier is 




Emerging Theme #3: Binational exchange of HIV medical records 
 Key informants identified challenges for binational HIV clinical record, which included 
access, confidentiality, and patient consent concerns. Most key informants spoke about the need 
for timely access to medical records to facilitate care transition. They also mentioned the sub-
theme of privacy concerns as well as differences in how U.S. and Mexican health care 
practitioners handle sensitive information sharing—which is a barrier inhibiting the ability to 
share clinical history between the two countries. One way to address the privacy concerns is to 
ensure that the detained alien signs a consent form to release their medical records to Mexican 
health authorities, but uncertainty exists about whether this is currently being done in ICE 
detention. This concern was reflected in one local health official’s response: 
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So, when an HIV-positive patient shows up at the CAPSITS, you can imagine if 
somebody who's been under HIV treatment for several years, and they’ve had maybe a 
complicated clinical history, the doctors on the Mexican side don’t have that clinical 
information. And if the patient doesn’t remember the name and dosage of everything he 
or she is taking, then that’s a real barrier right there for them to start up HIV treatment 
right away.  
 
Emerging Theme #4: ICE procedures for HIV care transition 
 Two sub-themes emerged in discussions about coordination gaps between U.S. state/local 
and ICE health officials and Mexican health officials. First, key informants spoke about the need 
for ICE officials to coordinate with other stakeholders before removing a Mexican alien who will 
need a medical handover. Without this referral from ICE to local and state health departments in 
the United States, there are limited opportunities for patient education pre-departure, and the 
possibility of unsuccessful HIV care transition increases. Second, key informants spoke about the 
need to provide trainings to ICE clinicians and staff regarding the public health concerns, and 
importance, related to effective care coordination. One state health official responded as follows:  
So, with some ICE authorities, they don’t share timely information regarding people that 
they are going to repatriate back to Mexico. For example, one of the challenges that 
exists is that when ICE is going to send back someone to Mexico, they do it randomly. 
For example, they will release a patient maybe at 2:00 in the morning at a specific bridge. 
And then that person has to cross the border at night and then just find their way in the 
border town because they were sent back with no Mexican health officials available to 
receive them, et cetera. So, if we improve communication and we have people 
coordinating the entry of these sick aliens back into Mexico, then it will be coordinated to 
have a clinician waiting to meet the patients. So, they’ll be free from having to make it on 
the streets of Juarez and then, and then the next day they’re in Tijuana or maybe 
somewhere else, and they already spread the disease. So, I think, I think that 
communication between everyone that is involved is crucial, beginning with ICE and 
then especially the Mexico and U.S. health authorities.   
 
Emerging Theme #5: Educating HIV-infected aliens in ICE detention before removal 
 Most key informants spoke about the need for routine education of HIV-positive 
detainees in ICE facilities regarding the importance of continuing care and treatment and where 
to access services. Given that the eventual success of the care transition rests on whether the 
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repatriated alien continues treatment, educating them about what HIV/AIDS is, how it is 
transmitted, why they should treat it, and how to access care is important. The key stakeholders 
who spoke about this theme underscored that the education should take place while the alien is in 
ICE detention and should not wait until they return to Mexico. One academic stated, “I think that 
education is crucial. I mean, the HIV-infected people being repatriated need to be aware of what 
to expect when they return so they can be prepared.”  
Qualitative Results for Research Aim #3 
In order to answer aim #3, key informants were asked four questions about the ideal HIV 
care transition process and lessons from TB care transition—or other models. Two themes 
emerged from their responses: 1) binational protocols and 2) ICE detention standards for medical 
care, represented in Table 12.  
Table 12. Qualitative Results for Research Aim #3 
Aim #3: Explore whether there are lessons from tuberculosis care transition for detained, TB-infected aliens 
removed from the United States to Mexico that can be applied to HIV care transition, and/or if there are other 
models that could inform the research question. 
Interview questions: 
• What would an ideal HIV care transition process look like to you? 
• How would you describe the current situation regarding tuberculosis care transition for detained aliens 
removed to Mexico? 
• What would an ideal TB care transition process look like to you? 
• In addition to tuberculosis, are you aware of models of care transition in other settings that might provide 
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“As it relates to the actual care transition of a detained 
HIV-infected migrant, Mexico and the U.S. should 
establish international data and medical record sharing 
agreements, perhaps leveraging existing CureTB or 
Migrant Clinicians Network infrastructure and 























































providers in both 
countries to facilitate 
HIV health care access 
 
 
Ensure the appropriate 
levels of government 
from the United States 
and Mexico are 
informing and driving 
the decision-making for 
any process developed  
 
For a protocol or model 
to be effective, it will 
need to work within the 
state and local situation  
 
 
Implement ICE’s HIV 
care transition 
guidance for removed 
aliens (provide 
HIV/AIDS medication, 
referrals to providers, 
and a medical care 
summary) 
 
“It’s about the three C’s. It’s the communication, the 
coordination, and then the collaboration. And it has to 
be in that order. I mean, you have to start with 
communication, listening to our colleagues on the 
Mexican side. That allows us to then coordinate all the 
things that we're doing.” 
 
“If you try to do things only at a local level, um, they’ll 
work for a little while, but then they’re going to fail 
because it wasn’t a policy change at a state level. 
Allowing the communication and coordination 
decisions to be made at the state, and then bringing 
those decisions to the local level, you’re ensuring that 
the process is going to happen, is going to live on.” 
 
“Part of the reason of the success in Arizona [for TB 
care transition] is that the overall volume of ICE 
detainees in Arizona isn’t huge. So, it’s not like San 
Diego’s San Ysidro port of entry, or El Paso’s.” 
 
“The ideal scenario is that if somebody’s being 
deported and has HIV, that those removals would 
happen the right way. And so, when we know that an 
ICE detainee is HIV-positive, we know that he or she is 
on treatment, that, prior to his or her removal date or 
removal date, the state health authorities would be 
notified, and we would coordinate with Mexico on the 
health transition. It is our job to do that coordination, it 
should not be a burden on ICE.” 
 
 
Emerging Theme #6: Binational Protocols. Most key informants spoke about the need 
to foster local, state, and federal collaboration between the United States and Mexico to improve 
the ability to provide information and organization for HIV care transition of detained aliens. 
The most important sub-theme key informants mentioned was the need for data and medical 
record sharing agreements. Most of the key informants spoke about ensuring that the Mexican 
Secretariat of Health perspective is an integral part of any created process. Several key 
informants underscored the need to create the protocols at the state and/or local level, 
highlighting the diversity in state and local regulations and protocols for how to engage with 
Mexico. However, this diversity could mean instead that uniform federal standards would be 
easier, especially as ICE is a key player and local protocols would mean that ICE would have to 
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deal with many different jurisdictions and bureaucratic entities. One state health official affirmed 
by stating the following: 
And uh, and so now the way we’ve approached it, we’ve made sure that we’re working 
with the Mexican Ministry of Health, that they know what’s going on, that the Mexican 
state HIV program director is involved in all the decisions. And it’s working a lot better. 
We need that buy-in from our Mexican colleagues. Mexico has to be an integral part of 
the solution … You know, understanding the differences in our health systems, 
understanding the hierarchy differences on the Mexican side, that on the U.S. side 
sometimes we just don’t get. Or we don’t pay attention to the importance of it.  
 
Emerging Theme #7: ICE Detention Standards for Medical Care. Several key 
informants spoke about the need to implement ICE’s HIV care transition guidance for removed 
aliens, which is in their detention standards. The HIV care transition guidance includes the 
provision of 30-days of HIV/AIDS medication, referral(s) to providers, and a printed out medical 
care summary. If ICE were routinely providing these items, the HIV care transition process could 
improve. One NCO official noted, “The transnational continuity of HIV care is complex and 
creating a robust public health approach to it will require political will from the United States 
and Mexico.”  
Discussion 
How the Analysis Ties Back to the Primary Research Question 
The research sought to answer the question: How can HIV care transition be improved 
when ICE repatriates detained aliens to Mexico? The results from the key informant interviews 
and secondary data analysis explored perceptions of the current quality of HIV care transition, 
identified challenges with the care transition process, and explored lessons from other programs 
(TB) that could inform the HIV care transition process. The secondary data analysis found that 
while under-reported, ICE is repatriating an average of 2-3 HIV-infected aliens to Mexico every 
two weeks. This estimate is useful for assessing the demand on ICE for HIV care transition for 
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HIV-infected detainees repatriated to Mexico. ICE detention standards (ICE, 2011, 2019) state 
that ICE will provide aliens with three things upon repatriation: 1) medical care summary, 2) 30-
day supply of HIV/AIDS medication, and 3) referrals to providers. These standards for HIV care 
transition are not routinely implemented. Because this study did not include the federal 
government (ICE) perspective, it is unclear why the standards are not taking place. Exploring 
why they are not happening is a potential area for future research (see Recommendations for 
future research below). Key informants underscored that U.S. and Mexican health authorities 
have created state and local protocols to link HIV-infected aliens leaving the United States with 
HIV/AIDS care services in Mexico. These protocols include getting relevant medical history 
from ICE and sharing it with Mexican health officials, coordinating on a time and location for 
the repatriation so that there is a Mexican health official present to meet the alien upon removal 
and provide him/her with linkage to care in Mexico. Several key informants mentioned that if 
ICE did bring in the U.S. health authorities regarding removals of HIV-infected aliens, the health 
authorities could facilitate confirming the date and time for the removal and could take 
responsibility for the care transition itself—alleviating ICE of needing to oversee the care 
transition process.  
While removed HIV-infected aliens should have their medical care summary (which 
includes the necessary treatment information that Mexican clinicians will need), in the long-term, 
most key informants spoke about the need for more formal binational coordination at all levels of 
government (federal, state, local), across both ICE and health authorities, in both countries. Most 
key informants recommended formal data and medical sharing records agreements that address 
issues of access, confidentiality, and patient consent.  
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Study Limitations  
This study entailed a number of limitations. First, the exclusive reliance on English-
language studies in Chapter 2 (Literature Review) may mean that not all the evidence available 
was represented regarding HIV and/or TB care delivery within the immigration detention system 
in the United States and/or care transition upon removal to an alien’s country of citizenship. 
Second, a possible limitation of the qualitative study was that it was limited to nine key 
stakeholders. (Note: UNC advises students to limit key informant interviews to nine as Office of 
Management and Budget [OMB] clearance is not required for fewer than ten participants.). 
When fewer than 15 people are interviewed, it can be difficult to demonstrate the validity of the 
findings. Although the number of key informant interviews was low, the results confirmed many 
of the literature findings, indicating there are enduring challenges for HIV care transition that are 
not likely to dissipate without intervention. Third, the investigator could have introduced bias 
into the coding of the qualitative interviews because interpretation of the findings could have 
been unavoidably shaped by their background, female gender, culture, history, and 
socioeconomic origin (Creswell & Creswell, 2018). To address this bias, interviewees were 
asked to review, affirm, or modify transcripts of their interviews. The investigator also worked 
with a second coder to interpret themes and reconcile the findings. Fourth, the key informants 
may have misclassified their responses or interpreted the questions through their own personal 
lenses and experiences, even though the investigator reviewed definitions of terms at the 
beginning of the telephone interview. In some cases, survey respondents were not able to answer 
all the questions due to tenure, experience, or involvement in only a particular aspect of the 
work. Fifth, the lack of patient perspective(s) (i.e., the voice of the HIV-infected Mexican alien 
repatriated to Mexico by ICE) was an important limitation of this exploratory research. It is 
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important to understand from their perspective what factors contribute to successful HIV care 
transition. However, directly interviewing the aliens was outside the scope of this exploratory 
research study. Sixth, the results of the mixed methods exploratory research suggested that 
even while under-reported, the number of HIV-infected aliens repatriated to Mexico is not 
insignificant (average of 2-3 removals of HIV-infected aliens every two weeks).  
Recommendations for Future Research 
Based on the results of this mixed methods study, recommendations for future 
research included the following: 1) learning more about the challenges and opportunities for 
implementing ICE detention standards (ICE, 2011, 2019) that govern what to provide HIV-
infected detained aliens upon release into the United States/repatriation to the country of 
citizenship (i.e., medical care summary, referral to community providers, 30-day supply of 
medicine); 2) more accurately measuring the prevalence of HIV/AIDS in Mexican aliens 
detained by ICE and the prevalence in the population of ICE detainees repatriated to 
Mexico; 3) analyzing the outcomes of HIV-infected detained aliens linked to continued 
HIV/AIDS care in Mexico (e.g., ART adherence) and examining factors contributing to 
successful outcomes and those inhibiting success (e.g., stigma, CAPASIT access); 4) 
prospectively researching the impact that Mexico’s new health care scheme (INSABI), 
introduced January 2020, will have, or not have, on HIV treatment access for repatriated 
HIV-infected aliens; and 5) exploring ways to increase HIV testing in ICE facilities as well 
as unintended outcomes of increased testing/changes in the ICE HIV testing protocol. 
Conclusion 
ICE is repatriating an estimated 2-3 HIV-infected Mexican aliens every two weeks. 
According to the key informant interview results, opportunities exist to enhance HIV care 
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transition for these HIV-infected aliens upon repatriation to Mexico. Opportunities on the 
front-end—while the HIV-infected aliens are in ICE custody—include the following: 1) 
educating HIV-positive ICE detainees about HIV/AIDS, the importance of treatment 
adherence, and how to access HIV services in Mexico upon repatriation and 2) educating 
ICE clinicians about how to connect HIV-infected detainees to care when they are 
repatriated to Mexico.  
Opportunities to improve the care transition process for HIV-infected ICE detainees 
included the following: 1) implementing the ICE detention standard for HIV care transition 
by repatriating HIV-infected aliens with a 30-day supply of medication, a copy of their 
medical care summary, and a referral to a community provider in Mexico and 2) having ICE 
coordinate with U.S. local and/or state health authorities before removing an HIV-infected 
alien so that the U.S. health authority can coordinate with their Mexican counterparts to 
have someone meet the alien upon arrival to Mexico and ensure care transition takes place. 
Post-repatriation opportunities to improve access to HIV/AIDS care and treatment 
that this research identified included the following: 1) addressing stigmatization (identified 
in the literature review in Chapter 2); 2) ensuring each repatriated alien has their CURP 
number (Mexican federal ID # or the “Clave Unica de Registro de Población”); 3) addressing the 
challenge of access to a CAPASITS for care and treatment (i.e., physical distance, lack of 
money to pay for transportation there); and 4) providing Mexican clinicians with HIV 
medical records/history to continue effective and proper treatment (e.g., binational 




Finally, creating binational protocol(s) for the exchange of medical records/clinical 
information, coupled with the implementation of an HIV care transition program—possibly 
modeled after CureTB—could potentially address many of the identified barriers for care 
transition. This proposal generated by input from key stakeholder interviews was included 
in the policy options considered in Chapter 5 (Policy Analysis). 
Table 13. Summary of Key Themes and Suggested Solutions from  
Key Informant Interviews  
Theme #1: Access to HIV services in Mexico 
• Ensure HIV-infected aliens have a Mexican federal identification number  
• Address the challenge of how to physically access HIV care and treatment services 
Theme #2: Coordination between ICE and U.S. and Mexican health authorities for the 
repatriation of HIV-infected aliens 
• Ensure that U.S. and Mexican health authorities are notified in advance about the 
removal of an HIV-infected alien in ICE custody as they can arrange for the care 
transition of the alien (i.e., ensure a Mexican health representative meets the alien at 
the border to escort them through their linkage to HIV care and treatment) 
Theme #3: Binational exchange of HIV medical records 
• Address three challenges for U.S.-Mexico medical record sharing: access, ensuring 
confidentiality, and patient consent 
Theme #4: ICE procedures for HIV care transition 
• Educate ICE clinicians about how to connect HIV-infected aliens to care in Mexico  
Theme #5: Education of HIV-infected aliens in ICE detention 
• Educate HIV-infected detainees in ICE facilities on the importance of continuing care 
and treatment, and about how HIV care services operate in Mexico 
Theme #6: Binational agreement(s) for the exchange of data and medical records 
• Establish data and medical record sharing agreement(s) and ensure that the appropriate 
levels of government (local, state, federal) from the United States and Mexico are 
informing and driving their development 
Theme #7: ICE detention standard for HIV care transition 
• Implement ICE’s detention standard for HIV care transition for removed aliens (i.e., 


















CHAPTER 5: POLICY ANALYSIS  
 
 
This chapter considers policy options to address the primary research question: How can 
HIV care transition be improved when U.S. Immigration and Customs Enforcement repatriates 
detained aliens to Mexico? The policy options are based on the results of Chapter 4. Policy 
analysis is the process of identifying potential policy options, ranking each one based on defined 
criteria, and selecting the final policy option to pursue. The results of this policy analysis are 
used in Chapter 6 (Plan for Change), which focuses on creating a plan to actualize the selected 
policy option. 
Methodology 
This policy analysis was based on Bardach’s eightfold path (Bardach & Patashnik, 2015). 
Bardach’s eight steps for policy analysis—which echo to a large extent the steps taken in this 
dissertation—are as follows:  
1) Define the problem (needs statement): Define the problem’s magnitude.  
2) Gather background evidence: Describe the gaps, key players, existing resources, and 
identify policies/programs that have been tried in other places to address the same or 
similar problem. 
3) Construct alternatives: Brainstorm a list of possible strategies (policy options) to 
address the problem and include the “status quo” as one of the options; strategies can be 
combined to form a policy option.   
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4) Select the criteria to evaluate the policy options: Define the criteria; include three 
criteria: cost to implement, political feasibility, and impact. Consider whether to weight 
each criterion differently.  
5) Project the outcomes: Evaluate each policy option against the criteria; incorporate 
qualitative information or quantitative (cost-benefit, modeling) methodology to evaluate 
the options; and consider the minimum level of effectiveness the policy needs to have to 
justify the expenditure/change and recognize the difference between 
economically/technically feasible and politically acceptable alternatives. 
6) Confront trade-offs: Consider the outcomes of each policy option.  
7) Decide: Identify the strongest option. 
8) Tell the story: Explain the problem and potential solutions (i.e., write this chapter and 
the plan for change in Chapter 6).  
This chapter (Policy Analysis) focuses on Bardach’s steps 3-8. The following sections describe 
the evaluation criteria and policy options selected for this policy analysis. The concluding section 
of this chapter describes limitations to this policy analysis. 
Policy Options 
 To strengthen the care transition for HIV-infected aliens removed by ICE from the 
United States to Mexico, this policy analysis evaluated the following five policy options—two of 
which are combinations of policy options: (1) repatriate without support (maintain the status 
quo); (2) repatriate with a supply of medication (provide HIV-infected aliens with a 90-day 
supply of ART upon removal); (3) repatriate with ICE medical care summary; (4) repatriate with 
community-based provider referral, ICE medical care summary, and a supply of medication (in-
line with current ICE detention standards); and (5) repatriate with community-based provider 
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referral, ICE medical care summary, and a supply of medication and binational data sharing. 
This fifth option was in-line with ICE detention standards for repatriation of HIV-infected aliens 
and would also include creating a binational platform for the sharing of data and medical records.  
These policy options reflect the key informant suggestions identified in Chapter 4 for ways to 
improve HIV care transition for detained aliens repatriated to Mexico.   
Evaluation Criteria 
 The “proposals (or “policies”) stream” in Kingdon’s (1984, 1995) MSF refers to the 
“soup,” which consists of a multitude of policy proposals. Many proposals may exist that attempt 
to address the same problem. To make it to the “shortlist,” each policy option was evaluated by 
five standard criteria: 1) cost to the U.S. federal government to implement; 2) the impact on 
improved binational HIV care transition; 3) the political feasibility of being adopted; 4) the ease 
of operational implementation; and 5) the impact on the health of the HIV-infected alien being 
removed. Four of these criteria reflected Bardach’s guidance on what to evaluate (Bardach & 
Patashnik, 2015): cost to the government to implement, political feasibility, health impact in the 
long-term (improved binational HIV care transition), and health impact in the short-term (impact 
on the health of the HIV-infected alien being removed). The additional criterion—ease of 
operational implementation—was selected to capture in the ranking the practicality of the policy 
options. How difficult is it to operationalize/put into use the policy option?   
Each assessment criterion was ranked from 1 (least meets the evaluation objective) to 5 (most 
meets the evaluation objective). To assess the cost of potential policy alternatives, the 
investigator examined affordability from the U.S. federal government’s perspective, such that a 5 
indicated the most affordable option for the government and 1 indicated the costliest option, 
requiring a significant budget appropriation from Congress or the reprogramming of agency 
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funds. Impact refers to the magnitude to which a policy option will effectively lead to HIV-
infected aliens removed to Mexico being successfully linked to continued care and treatment. 
This systems-level criterion has the potential to positively influence the number of HIV-infected 
aliens removed to Mexico who are successfully linked to continued HIV care. Therefore, this 
measure was given twice the weight. Political feasibility denotes the probability of a policy 
option successfully being enacted either through the legislative or regulatory process. Ease of 
operational implementation is a measurement of the ability of the U.S. Department of Homeland 
Security to implement the policy option. The immediate impact on the health of the HIV-infected 
alien being removed refers to the magnitude to which a policy option will ensure that there is no 
HIV treatment interruption for an individual alien. Higher scores relate to lower risk of treatment 
interruption. This individual-level criterion has the potential to positively influence the number 
of HIV-infected aliens removed to Mexico who are successfully linked to continued HIV care. 
Therefore, this measure was given twice the weight. 
Policy Assessment 
 The results of the policy analysis are described herein. Table 14 visually shows the 
rankings of the five policy options against the five evaluation criteria. The rationale for the 
ranking for each option is described below, by policy option. The end of this chapter presents a 
short discussion of the highest-ranked policy option(s). Chapter 6 (Plan for Change) explores the 






Table 14. Ranking of the Various Policy Options for Improving HIV Care Transition for 
Aliens Repatriated to Mexico by U.S. ICE 
 
*The overall ranking represents the summary of the evaluation criteria scores; the rankings for impact on improved 
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Policy Option #1: Repatriate without Support (Maintain the Status Quo)  
If no additional steps are taken to improve care transition for HIV-infected aliens 
repatriated to Mexico, then the developing HIV epidemic at the U.S.-Mexico border will 
continue to grow. As mentioned in Chapter 1, in Mexico, a large proportion of the country’s HIV 
infection has been associated with migration from the United States. Enhanced U.S. immigration 
enforcement and removal policies are leading to an increasing number of repatriations each year 
which, based on the estimate from Chapter 4 (Results and Discussion) of 2-3 repatriations of 
HIV-infected aliens every two weeks, could lead to hundreds of HIV-infected individuals at risk 
of treatment interruption, poor health outcomes, and ongoing transmission in receiving 
communities and at the border between Mexico and the United States each year. Ensuring 
uninterrupted HIV treatment is so critical to both the alien’s health and to prevent transmission in 
the community. 
• Affordability (5/5) – Given that no HIV care transition steps are taken under the status quo, 
no additional costs will be incurred, and no funds will need to be allocate by ICE or U.S. and 
Mexican public health authorities.  
• Impact on HIV care transition (1/5) – Given the absence of HIV care transition steps under 
the status quo, there is, therefore, no impact on improved binational care transition.  
• Political feasibility (5/5) – As no HIV care transition action will be pursued under the status 
quo, traditional political measures taken to support policy will be employed. 
• Ease of implementation (5/5) – Under the status quo, there is no policy/action to implement. 




• Impact on the health of the HIV-infected alien being removed (1/5) – Under the status 
quo, there is a high risk of HIV treatment interruption and, therefore, poor health outcomes 
for the alien being repatriated to Mexico.  
Policy Option #2: Repatriate with a Supply of Medication   
This policy option proposes to provide a 90-day supply of ART to HIV-infected aliens 
repatriated to Mexico by ICE. The current ICE detention standard is to provide a 30-day supply. 
Continued and consistent access to ART after repatriation to Mexico will help ensure continued 
viral suppression. In contrast, the repatriation alien takes steps to acclimate to Mexico, including 
accessing their Mexican federal ID number, known as the CURP (Clave Única de Registro de 
Población). The CURP is needed to receive health care under Mexico’s health program INSABI. 
INSABI is designed to provide comprehensive coverage for everyone, at any hospital or clinic 
belonging to Mexico’s public health system, at no cost to the patient. All medications are 
covered, including ART. Because a Mexican federal ID number (CURP) can be a challenge to 
receive as it requires proof of residential address, and because most return migrants to Mexico 
are more focused on securing employment than accessing health care, providing a 90-day supply 
of ART provides extra security for treatment continuation during the period immediately post-
repatriation.  
• Affordability (3/5) – The average cost in the United States for a one-month supply of ART 
is roughly $1,000 (Farnham et al., 2018). Based on the estimate of 63 HIV-infected aliens 
repatriated by ICE in FY 2018 (see Chapter 4, Results and Discussions), the additional cost 
to ICE to provide an additional 60-day supply of ART to all repatriated aliens is ~ $126,000. 
While not insignificant an amount, this sum represents 0.0002% of ICE’s total FY 2019 
enacted budget of $7.6 billion.   
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• Impact on HIV care transition (2/5) – This policy option will have minimal impact on 
improved HIV care transition because it is time-limited, and it does not improve upon/ensure 
linkage to HIV care after arrival in Mexico.  
• Political feasibility (2/5) – Because ICE is already required to provide HIV-infected aliens 
with a 30-day supply of ART upon removal, there is little political incentive for ICE to 
provide an additional 60-day ART supply to the alien to ensure they are covered once in 
Mexico. 
• Ease of implementation (4/5) – Because ICE should already have a system in place for 
providing HIV-infected aliens with a 30-day supply of ART upon removal, the addition of 60 
days of treatment should be relatively simple to implement.  
• Impact on the health of the HIV-infected alien being removed (4/5) – This policy option 
lowers the risk of HIV treatment interruption while efforts are made to ensure the alien has 
access to health services in Mexico.   
Policy Option #3: Repatriate with ICE Medical Care Summary 
Mexican providers are often uncomfortable prescribing ART without previous medical 
records. As described in previous chapters, HIV-infected aliens removed to Mexico are not being 
repatriated with their medical records and/or medical care summary from when they were in ICE 
detention. Without access to previous medical records (including drug resistance profiles), health 
care providers in Mexico might make inadequate changes to drug regimens of aliens with drug-
resistant HIV. Mexican citizens must provide certain documents to be able to receive HIV 
medications in Mexico, including a positive HIV antibody test result. For a repatriated alien, 
having access to their medical care summary could help facilitate a smoother transition to 
receiving HIV care in Mexico. This policy option would help to address the concerns outlined 
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and potentially make the linkage to care more efficient—at little cost to ICE. However, this 
policy option could place the burden on the alien to safekeep the physical medical care summary 
document during the removal process, which could be challenging and is a reason why policy 
option #5 provided herein is proposed. 
• Affordability (4/5) – This policy option would have limited additional costs to ICE as it 
involves providing each HIV-infected alien being repatriated to Mexico with a printed-out 
copy of their medical care summary, something ICE is required to do in its detention 
standard for HIV repatriation. The cost would be the limited staff time needed to compile and 
print the information.  
• Impact on HIV care transition (2/5) – This policy option will have a minimal impact on 
improved HIV care transition overall because access to medical records does not, in and of 
itself, enhance the linkage to care upon arrival to Mexico. What this policy will improve 
within the care transition process is the ability of the HIV-infected alien to receive treatment 
once connected with health services/CAPASIT. 
• Political feasibility (4/5) – This operational policy option is very low-cost and compelling 
because ICE is already required to provide HIV-infected aliens with medical care summary 
upon removal.  
• Ease of implementation (4/5) – Because ICE should already have a system in place to 
provide each HIV-infected alien with a medical care summary upon removal, this policy 
option should be relatively easy to implement.  
• Impact on the health of the HIV-infected alien being removed (3/5) – While a medical 
care summary will help ensure the HIV-infected alien receives appropriate treatment in 
Mexico, this policy option would have a mixed effect on the health of the alien because the 
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alien will still need to be linked to care in order for the care summary to be able to impact the 
health of the HIV-infected alien. 
Policy Option #4: Repatriate with Community-based Provider Referral, ICE Medical Care 
Summary, and a Supply of Medication  
This policy option, which builds upon policy options #2 and #3, would have ICE 
implement its detention standard for the release/removal of HIV-infected aliens: “Detainee will 
be provided medication (a 30-day supply for HIV/AIDS), referrals to community-based 
providers, and a medical care summary” (NDS, 2019 & PBDNS, 2011). As established in 
previous chapters, this detention standard is not currently being implemented with regularity.  
• Affordability (3/5) – While this policy is already a requirement of ICE, it is not currently 
being implemented, which would mean there would be costs to beginning and maintaining its 
implementation—from staff time to compile and provide the medical summary and conduct 
the necessary outreach and research to be able to provide a provider referral in Mexico to pay 
for the 30 days of medication.  
• Impact on HIV care transition (3/5) – This policy option would have a mixed impact on 
the HIV care transition process. While it is the recommend “HIV care transition” provision 
for ICE, it does not include one very important component discussed in previous chapters—
the need to physically meet the alien upon arrival and escort him/her to the CAPASIT and 
ensure the alien understands why continuing treatment is important.   
• Political feasibility (3/5) – Because ICE is already required to provide this policy option, it 
should not need political measures to ensure it is enacted. However, because this detention 
standard is not currently implemented, there will need to be support for this operational 
policy to ensure it happens.  
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• Ease of implementation (3/5) – Because ICE is already required to provide this policy 
option, it should be easily implemented. However, because this detention standard is not 
currently implemented, there will be start-up costs in terms of staff time, training of staff, the 
purchase of medication, and other demands as the detention standard is operationalized. 
• Impact on the health of the HIV-infected alien being removed (4/5) – This policy option 
should positively impact the health of the HIV-infected alien by providing the removed alien 
with a supply of medication to help ensure there is not treatment interruption while the 
referral and care summary will help the alien access care and treatment.  
Policy Option #5: Repatriate with Community-based Provider Referral, ICE Medical Care 
Summary, and a Supply of Medication; Binational Data Sharing 
This policy option builds upon policy option #4 as it would have ICE implement its 
detention standard for the release/removal of HIV-infected aliens: “Detainee will be provided 
medication (a 30-day supply for HIV/AIDS), referrals to community-based providers, and a 
medical care summary” (NDS, 2019, & PBDNS, 2011). However, this policy option would also 
include the development and use of a legally and ethically sound online platform for sharing 
data/medical records to strengthen the coordination of HIV linkage to care for between the 
United States and Mexico. This platform would be complemented with a protocol governing how 
the platform is used, how the data is shared, and who has access to it. With these components 
combined, this policy could become a U.S.-Mexico HIV/AIDS continuity of care program 
focused on linking repatriated HIV-infected aliens with care services at their final destination—
and ensuring all the necessary medical records/data reaches the providers. It would also include 
providing the alien with a 30-day supply of ART upon removal and engaging directly with the 
HIV-infected alien before repatriation (while in ICE detention) to educate them about their 
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disease and the importance of treatment adherence. Key informants identified available, 
instructive TB models in formulating such a care transition program. Two such examples are 
described later in this chapter. This policy option has the opportunity to have the largest impact 
on HIV care transition and on the health of the HIV-infected alien being repatriated, but it will be 
challenging to implement due to the cost, challenging to build political support, and would take 
much work to implement. 
• Affordability (2/5) – While aspects of this policy option are already a requirement of ICE 
for repatriation, none of the components of this policy option are currently happening. 
Consequently, there will be start-up costs and costs to maintain the program, including the 
online platform.  
• Impact on HIV care transition (5/5) – This policy option is focused on improving the HIV 
care transition process via the creation of a care transition program. For this reason, the 
impact of this policy option on HIV care transition is large. 
• Political feasibility (2/5) – Because the number of impacted aliens in ICE custody is small 
(N=63 across all ICE facilities, based on FY 2018 numbers) and the prevalence of HIV in 
Mexico is relatively low, the political support for creating a new program for HIV care 
transition may be limited.   
• Ease of implementation (2/5) – This is the policy option that will require the most effort to 
implement. In terms of operationally implementing this option, it will require a negotiated 
protocol between ICE and U.S. and Mexican health authorities about how the HIV care 
transition program will operate. The data-sharing platform will have to be built and managed. 
Additional staff may need to be hired by the U.S. and Mexican health authorities to ensure 
individuals are available to visit with and educate HIV-infected ICE detainees prior to 
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repatriation and to coordinate the actual care transition process. In regards to implementing 
the ICE detention standard—since ICE is already required to provide this policy option—it 
should be easily implemented. However, because this detention standard is not currently 
implemented, there will be start-up costs in terms of staff time, staff training, the purchase of 
medication, and other demands as the detention standard is operationalized. 
• Impact on the health of the HIV-infected alien being removed (5/5) – This policy option 
would positively impact the health of the HIV-infected alien by providing the removed alien 
with all the identified components to support HIV care transition: education about the 
importance of continuing HIV treatment uninterrupted, linkage to care, a supply of 
medication, the provision of medical records to the clinician treating the alien, and enhanced 
coordination between ICE and U.S. and Mexican health authorities. 
Policy Recommendations 
This policy analysis showed that the strongest option (i.e., highest scoring) for improving 
HIV care transition when ICE repatriates detained aliens to Mexico is to couple the creation and 
use of an online platform for sharing data/medical records with ensuring that HIV-infected aliens 
are repatriated with a copy of their care summary while in ICE detention, a referral to a provider 
for continued treatment, and a 30-day supply of HIV medication. One way to approach this 
policy proposal is to establish a U.S.-Mexico HIV/AIDS continuity of care program that would 
include creating a binational platform for sharing data and medical records; linking repatriated 
HIV-infected aliens with care services at their final destination in Mexico (and ensure they reach 
their final destination); providing the aliens with a 30-day supply of medication to ensure no 
treatment interruption occurs; engaging directly with HIV-infected aliens before repatriation 
(while in ICE detention) to educate them about their disease and the importance of treatment 
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adherence; and educating ICE clinicians about the importance of HIV care transition. Through 
the literature search (Chapter 2) and the key informant interview results (Chapter 4), two 
programs currently exist that can inform creating such a program: CureTB and the TB “Meet and 
Greet” Program. These two programs are described in more detail further. 
Because of inherent challenges to implementing a U.S.-Mexico HIV/AIDS continuity of 
care program immediately (to be explored in depth in Chapter 6), a short-term step toward this 
longer-term policy goal is to pursue the next highest scoring policy option, which is to have ICE 
implement its standard for HIV care transition and provide all repatriated aliens with a copy of 
their ICE medical care summary, a 30-day supply of ART, and referral(s) to community-based 
providers. This policy option plays a critical role in ensuring HIV care transition and is a viable 
option politically because it is already an ICE detention standard, so it does not involve creating 
any new program. How best to pursue implementing the short- and long-term policy options will 
be explored further in Chapter 6. 
Program 1: CureTB 
 
 Established in 1997 within the TB Control Branch of the San Diego County Health and 
Human Services Agency, CureTB provides continuity of care for patients with TB who move out 
of the United States before completing treatment, including those removed by ICE (San Diego 
County Health and Human Services Agency, 2019). Although program operations transferred to 
U.S. CDC in 2016, CureTB retains a partnership with the San Diego County TB Control Branch.  
CureTB functions as an information exchange and facilitation service for TB care 
transition. CureTB includes components of the selected policy option from the analysis 
conducted in this chapter—the program provides diagnostic and treatment history information to 
the receiving country’s health officials and coordinates for TB care transition for the alien at the 
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point-of-arrival into their country of record. CureTB educates patients (including detained aliens 
prior to removal) about TB disease, the importance of treatment adherence, and how to access 
TB services. CureTB also has educated ICE clinicians about the importance of care transition. 
What is less clear is how CureTB’s data platform operates and who has access to it. Between 
2012 and 2015, 28% of referrals to CureTB for patients with verified or possible TB disease 
came from law enforcement agencies, including ICE, and 88% of those referrals were for an 
alien scheduled to be repatriated to Mexico (Figueroa et al., 2020). In 2017, 3.1% (287 out of 
9,253) of patients with TB in the United States were in ICE detention at the time of diagnosis 
(Figueroa et al., 2020). Among patients with verified TB disease who were referred to other 
countries by CureTB, 78% completed treatment (Figueroa et al., 2020). These results show that 
with appropriate procedures and good implementation, transition of care can be accomplished.  
Program 2: Arizona’s TB and HIV Meet and Greet Programs 
  
Arizona has launched a nascent HIV care transition program for detained aliens 
repatriated to Mexico modeled on the state’s TB “Meet and Greet” program. The TB program, 
which is described in more detail herein, includes all the components identified in the selected 
policy option from the analysis conducted in this chapter. Specifically, there is a data-sharing 
platform between ICE, and U.S. and Mexican health authorities at the state level (Arizona and 
Sonora). Repatriated aliens are physically met at the border upon removal in order to facilitate 
linkage to TB care and treatment; and detainees and ICE clinicians are educated by 
representatives from the Arizona Department of Health Services (ADHS) prior to repatriation.  
ADHS and public health officials in Sonora, Mexico, have conducted this collaborative 
“Meet and Greet” program since 2002 (Lewis, 2006). The objective of the “Meet and Greet” 
program is to provide medical case management to encourage repatriated aliens to continue and 
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complete TB treatment despite repatriation to Mexico. The program is designed to address the 
problems created when people with active pulmonary TB are repatriated before their TB 
treatment is completed.  
The TB “Meet and Greet” program involves the coordination of binational public health 
authorities and U.S. law enforcement staff. ICE detention facilities notify the local health 
department in Arizona of an impending removal of a detained alien being treated for TB. The 
local health department then contacts ADHS who notifies the TB program in the state of Sonora 
in Mexico (note: Arizona borders Sonora). The goal is to set a date and time for the repatriation 
(i.e., properly time the removal of the alien) so that there is the presence of Sonoran public health 
officials at the designated port-of-entry to meet the alien and facilitate linkage to continued 
treatment. Before repatriation takes place, an educator from ADHS will meet with the detained 
alien in ICE detention to educate them on TB, the importance of completing treatment, and how 
they will be linked to care upon removal to Mexico. Over the last few years, Arizona has begun 
an identical program for HIV called the HIV “Meet and Greet.” There is no information 
available (yet) on the HIV “Meet and Greet” program in the published literature. Its existence 
was raised in the key informant interviews.  
Arizona uses a medical electronic disease surveillance intelligence system (MEDSIS) 
(Arizona Department of Health Services, 2020). It is a statewide, secure (HIPAA compliant), 
web-based, centralized, person-based disease surveillance system hosted and supported by 
ADHS for use by providers and institutions responsible for reporting communicable diseases and 
for local health departments to conduct disease surveillance. It is updated in real-time; 
information entered into MEDSIS is immediately accessible by the local health department. Only 
approved MEDSIS users have access to data submitted by a provider. To facilitate the TB and 
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HIV “Meet and Greet” program, representatives from the Sonoran Department of Health have 
access to MEDSIS as do CureTB representatives and correctional facilities in Arizona, including 
ICE detention facilities. For TB and HIV care transition, the U.S. and Mexican authorities 
communicate using the alien’s MEDSIS number and not their name. 
Limitations 
In this policy analysis, the researcher solely conducted the rankings. The rankings do not 
include direct input from people who can provide and/or interpret information about the policies 
(i.e., subject matter experts, economists), people affected by the policy (e.g., ICE clinicians, 
HIV-infected Mexican aliens detained by ICE, U.S. and Mexican health authorities), nor people 
who administer resources related to the policy (e.g., public officials). In Bardach’s eightfold path 
(Bardach & Patashnik, 2015), he makes the point that the extent to which evidence is assembled 
to evaluate each policy option involves a balancing of the “costs” needed to obtain the evidence 
versus the extent to which the new evidence would lead to better policy options. Because the 
rankings incorporate qualitative methodology (input from the key informant interviews) and 
information available in the published literature, it is not clear that new evidence provided by the 
groups listed above would necessarily lead to better rankings. Because the rankings are 
subjective, the rationale for each is documented in this chapter.  
A limitation to this policy analysis is that several identified barriers in the care transition 
of HIV-infected aliens repatriated to Mexico were not explicitly addressed in one of the policy 
options. These barriers, identified in the literature review (Chapter 2), relate to challenges faced 
by the HIV-infected aliens once they are repatriated to Mexico. They include stigma and mistrust 
of Mexican state and local government (due to state and local politicians expressing hostility 
regarding immigrant access to services), which impact willingness to use government health 
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services (e.g., a CAPASIT), and transportation challenges to reaching a CAPASIT for regular 
care (they are not yet ubiquitous all over Mexico). Because this research focused on how to 
improve the actual point of HIV care transition between the United States and Mexico and less 
on the barriers to continued care on the Mexican side, these identified challenges have been 















CHAPTER 6: PLAN FOR CHANGE  
 
 
The policy analysis in Chapter 5 identified two policy options to improve HIV care 
transition. The strongest option for improving HIV care transition is the development of a U.S.-
Mexico HIV/AIDS continuity of care program that would include a platform for the sharing of 
HIV data and medical records. The CureTB program and Arizona’s TB and HIV “Meet and 
Greet” program described in Chapter 5 could serve as useful models for a national program. In 
addition, expanding the CureTB program to include HIV could be a possibility to address the 
long-term policy option. A short-term step toward this longer-term policy goal is to ensure 
implementation of extant ICE standards for HIV care transition, which include the provision of a 
30-day supply of HIV/AIDS medication, referrals to community-based providers, and a medical 
care summary. This short-term policy option plays a critical role in ensuring HIV care transition 
and could be a viable option politically since it is already an ICE detention standard, so it does 
not involve creating any new program or allocating additional funding.  
 If implemented, these policy solutions should improve HIV care transition for detained 
aliens removed by ICE to Mexico. In fact, the U.S.-Mexico HIV/AIDS continuity of care 
program should include the collection of outcome data to measure whether the program is 
successful in linking repatriated HIV-infected aliens to continued care in Mexico (and therefore 
not causing treatment interruption). But how can the policy solution(s) grounded in the results of 
the mixed-methods research be packaged and transformed into meaningful policy change? Using 
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Kingdon’s (1984, 1995) MSF as a model, this chapter will describe an approach to pursue these 
policy options. 
The Policy Stream: ICE’s HIV Care Transition Detention Standard 
 In regard to pursuing the short-term policy option, ICE should already have the funding 
allocated for implementation of its detention standards (2011 PBNDS and the 2019 NDS) via 
Congressional appropriation to DHS. This means that the policy action needed relates to the 
implementation of ICE’s HIV care transition detention standards—in other words, an operational 
policy change. After consultation with various stakeholders, including dissertation committee 
members, it was decided that the best approach would be to pursue this policy option at the 
program level—by engaging with the leadership of IHSC who oversee the medical care 
detention standards. The goal of the engagement would be to learn about the barriers ICE is 
facing regarding implementing the HIV care transition standard as well as the levers that need to 
be “pulled” for ICE to begin to implement the care transition standard and coordinate with the 
health authorities ahead of repatriation. Since ICE is reportedly implementing these standards in 
Arizona—through ICE’s participation in Arizona’s HIV “Meet and Greet” program—it could be 
the levers are more straightforward to “pull.” In particular, the case might be easier made when 
sharing the estimated number of HIV-infected aliens ICE repatriates each year to Mexico from 
across all ICE facilities in the United States (based on FY 2018 secondary data): 75 aliens. While 
this is most likely an underestimate of the true number of HIV-infected aliens ICE repatriates to 
Mexico, it does give an indication of the current volume ICE is handling for which it would need 
to ensure care transition.  
  An ideal forum to consider approaching IHSC leadership is via the U.S.-Mexico Border 
TeleECHO program (Border ECHO [Extension for Community Health care Outcomes]). The 
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goal of Border ECHO is to virtually connect key stakeholders along the U.S.-Mexico border 
working with migrant communities, including asylum seekers and recent migrants. Each of the 
closed sessions focuses on a topic that participants have requested. Sample topics include 
“Improving Communication with Customs and Border Patrol, Immigration and Customs 
Enforcement.” In addition to a more formal presentation, in each session, time is scheduled for 
problem-solving and brainstorming for any U.S.-Mexico border health problems or challenges 
that need immediate feedback and advising from the network of participants. Managed out of the 
University of New Mexico Health Sciences Center, the Border ECHO program includes 
participation from U.S. and Mexican health authorities at the local, state, and federal level.  
Because Border ECHO has convening power and, in the past, has worked to address 
topics related to ICE, the investigator will send a request to Border ECHO to consider convening 
a session to consider this policy topic. The information on how to contact the management team 
of Border ECHO is publicly available on the University of New Mexico’s website. To help 
inform the members of Project ECHO, the investigator intends to develop an executive summary 
of the results of this research and summarize this shorter-term operational policy 
recommendation. The hope is that the Project ECHO community will be able to use this 
summary and the subsequent presentation to provide input and next steps for engaging with 
IHSC regarding the implementation of the ICE detention standard for HIV care transition.  
The Policy Stream: U.S.-Mexico HIV Continuity of Care Program 
In regard to pursuing the long-term policy option of creating a national HIV care 
transition program, this policy proposal should not need legislation nor legislative oversight to be 
implemented. Rather, it can be a collaborative effort between key stakeholders: DHS/ICE and 
local, state, and federal health authorities in the United States and Mexico. Transnational data 
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sharing policies and platforms are not straightforward to implement, but instructive models are 
available, including CureTB and Arizona’s MEDSIS. In addition, one possibility to address this 
long-term policy option is to consider the inclusion of HIV/AIDS care transition into the CureTB 
program. In the early 2000s, the San Diego County Health Department oversaw a program under 
CureTB called CureTB Plus, and it focused on HIV/AIDS care transition (Ocaña M, personal 
communication, February 25, 2020).  
Similar to the shorter-term policy solution, the investigator intends to develop an 
executive summary of the results of this research and this long-term policy recommendation. The 
primary audience for the executive summary will be the Border ECHO Program. If requested by 
the Border ECHO program, a framework can be developed to outline the key components to be 
included in such a program. Border ECHO is a good convener to explore creating this program 
both because the architects of Arizona’s “Meet and Greet” programs are members and also 
because of the relationship that members of Border ECHO have to CureTB and other binational 
programs already working on HIV care transition. If this longer-term strategy can find a 
“window of opportunity” within the Executive Branch, then funding would most likely be able to 
be reprogrammed to support creating the program and the data/medical record exchange 
platform. This policy proposal does not need legislation nor legislative oversight to be 
implemented. Rather, it can be a collaborative effort between key stakeholders: DHS/ICE and 
local, state, and federal health authorities in the United States and Mexico. 
Another avenue to explore in considering this longer-term solution relates to HHS 
advisory committees. As mentioned in Chapter 1, a straightforward, formal process took place to 
create the now-formal policies for TB care transition in repatriated aliens. The investigator 
recommends a similar process be considered for HIV care transition in repatriated aliens. As a 
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reminder, in 2002, the CDC ACET recommended that a working group be formed to review 
problems with post-detention TB treatment of aliens. ACET recommended that removal should 
only occur after verifying that necessary treatment is available at the destination (Nolan et al., 
2003). In 2004, ICE implemented a policy allowing for a temporary “medical hold” so that the 
IHSC could arrange for continuity of care before removal (Fenton & Castro, 2006). In 2005, ICE 
formalized policies for referring medical cases to two organizations: CureTB (San Diego County 
Health Department, San Diego, CA) or TB Net (Migrant Clinicians Network, Austin, TX) 
(Schneider & Lobato, 2007).  
The longer-term solution of creating an HIV care transition program could be well-placed 
to be considered by another of CDC’s federal advisory committees—the Board of Scientific 
Counselors (BSC) which advises the CDC Deputy Director for Infectious Diseases (DDID) as 
well as the HHS Secretary concerning strategies, goals, and priorities for the programs and 
research within the three infectious disease national centers at CDC. The board consists of 17 
members as well as a liaison from the Public Health Agency of Canada and the Secretariat of 
Health of Mexico. Similar to the approach that ACET took to address TB care transition in 
migrants, including repatriated aliens, it could be that thought should be given to approaching the 
BSC, DDID. 
The challenge for this long-term policy option is its timing. As highlighted in Chapter 5, 
this policy option does not currently benefit from a window of opportunity that this researcher 
can see (as of Spring 2020). While an issue that the Mexican Secretariat of Health has raised in 
the recent past, the magnitude of the issue for HIV care transition is not fully clear. Data are not 
available on the prevalence of HIV/AIDS in aliens repatriated by ICE to Mexico. Few aliens in 
ICE detention are known by ICE to have HIV/AIDS (a topic to be potentially be explored 
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further, but it is outside the scope of this dissertation). HIV/AIDS does not rise to the same level 
of concern for ICE staff, as say, TB. Based on the investigator’s calculations using FY 2018 
secondary data (see Chapter 4), only an estimated 63 aliens are diagnosed with HIV/AIDS each 
year in ICE detention. Therefore, the recommendation for this policy option is to keep it as 
longer-term. Inform Border ECHO, write the executive summary, and wait for a “window of 
opportunity” to open.  
Because of the lack of a clear “window of opportunity” in Spring 2020, this chapter 
further explores an alternate policy option that could help with meeting the goals being sought—
to exchange HIV/AIDS data and medical records between the United States and Mexico. This 
policy option does have a “window of opportunity” in Spring 2020.  
Implementing the Policy Solution(s) Using Kingdon’s MSF  
Figure 6 visually outlines the main question this exploratory research aimed to address: 
the political milieu as it relates to the problem and the proposed policy solution(s) described 
earlier. According to Kingdon, these three streams need to come together at the right time (“a 


















Figure 6. Applying Kingdon’s (1995) MSF to Create HIV Data and Medical Sharing 








The Political Stream: Actualizing the Policy Recommendation(s) 
 
Broadly speaking, Kingdon’s “political stream” refers to the milieu of community, 
governmental leaders, advocates, and stakeholders who have a voice in determining how the 
agenda is set for a given problem and the approach to address it. As noted earlier, new legislation 
is not essential. Moreover, the cooperation of the Executive Branch will greatly improve the 
likelihood of success because negotiating out the long-term proposal for a binational HIV 
continuity of care program (with a data exchange platform) will take cooperation of the 
Executive Branch. Given the strong interest in a solution beginning at the lowest point (program 
leads), already working with key stakeholders is a solution. The goal is a bilateral agreement 
with much detail. It will require buy-in from ICE.  
Optimal Window of Opportunity – An Area for Further Research 
In following Kingdon’s (1984, 1995) MSF and in light of the discussion above about the 























solution—it does seem that to gain executive branch (and if needed, legislative branch) support 
for a binational data/medical record exchange platform it needs to be larger than singularly 
focused on HIV.  
The Spring 2020 pandemic of SARS-CoV-2 could present two “windows of opportunity” 
to address the short- and long-term policy options. First, when the coronavirus situation is 
eventually over, there will be after action reviews and other analyses of how ICE managed the 
outbreak. These may prompt reconsideration of the overall public health standards for how ICE 
deals with detainees. So, this might present a window of opportunity for DHS to also look at 
HIV care transition guidelines and practices. Second, the pandemic may lead the Executive 
Branch to pursue a U.S.-Mexico, or even a U.S.-Mexico-Canada (i.e., North American) 
surveillance/medical record exchange platform to be able to determine a defined list of diseases 
of public health importance—and ensure HIV is on that list. To fully explore the SARS-CoV-2 
“windows of opportunity” and related policy options is beyond the scope of this research paper.  
As the Coronavirus pandemic is reminding everyone, in today’s globalized world, 
infectious disease threats have become transnational in nature and, therefore, require effective 
cross-border approaches to detect and respond to them. Given the length of the U.S.-Mexico 
border and its vulnerability to the introduction and rapid spread of potential threats to public 
health, it would be valuable to consider a policy option for all infectious diseases—perhaps 
modeled on Arizona’s MEDSIS platform discussed in Chapter 5. MEDSIS is a secure (HIPAA 
compliant), web-based, centralized, person-based disease surveillance system hosted and 
supported by ADHS for use by providers and institutions responsible for reporting 
communicable diseases and for local health departments to conduct disease surveillance. It is 
updated in real-time, and information entered into MEDSIS is immediately accessible by the 
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local health department. Only approved MEDSIS users have access to data submitted by a 
provider. This platform might be a helpful model for a larger, national platform because the 
MEDSIS model can support TB and HIV care transition for repatriated aliens while 
simultaneously serving as the surveillance system for the state. 
Pursuing a North American surveillance platform would be in line with over a decade of 
global efforts to develop new approaches to emerging and re-emerging infectious diseases—part 
of the growing recognition that disease events, whether natural, accidental, or intention, threaten 
not just public health, but national, regional, and global security interests (Crouse Quinn & 
Kumar, 2014). The two major platforms for country action emerging out of these global efforts 
are the Global Health Security Agenda and the revised 2005 International Health Regulations 
(IHR) (Kimball et al., 2008). Both platforms highlight the need for functional cross-border public 
health surveillance networks. The IHR (Article 21 on ground crossings, Article 44 on 
collaboration and assistance, and Article 57 on other international facilitating agreements) 
encourages neighboring countries to cooperate directly in disease surveillance sharing and 
coordinating responses to public health problems affecting more than one country (Heymann et 
al., 2015).  
Limitations of the MSF Model 
For the purposes of this research study, Kingdon’s (1984, 1995) MSF has three 
limitations: 1) it is a model that is most helpful to the legislative process and applies less to 
recommendations made of federal agencies; 2) it deals with policymaking under conditions of 
ambiguity when there are many ways to think about the problem whereas the results of this 
research showed that communication is the underlying issue; and 3) it requires that attention be 
paid to the issue by advocates/stakeholders to a degree higher than what might be needed to 
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encourage ICE to implement its detention standards or to encourage U.S. and Mexican 
authorities to work on creating a clinical data and medical record sharing platform. The 
development of protocols and processes can be done by motivated government employees 
without legislation from Congress.  
Conclusion 
 
This research supports U.S. and Mexican authorities to identify best practices, challenges, 
and opportunities for improved HIV care transition in the population of aliens detained by ICE 
and repatriated to Mexico. The exploratory research also provides insight into the current status 
of HIV care transition in this population and expectations for a well-functioning HIV care 
transition process. If implemented, the short- and long-term policy options will improve the 
communications, coordination, and binational collaboration for HIV and AIDS care transition. 
Further exploration of actions needed for ICE to strengthen the management of HIV-infected 
aliens in detention facilities, both with respect to enhancing testing of detained migrants and 
increasing implementation of ICE HIV care transition standards, would be fruitful. Avenues for 
further research that would help support advocacy and policy development to improve HIV care 
transition for repatriated aliens include carrying out studies to better define the prevalence of 
HIV/AIDS among detained aliens and determine the outcomes of HIV care transition for aliens.  
Given the seriousness of HIV infection, the clinical implications of interrupted antiviral 
therapy for individuals, and the availability of free HIV treatment in Mexico for all Mexicans, 
care transition for HIV-infected aliens detained by ICE who are repatriated to Mexico is 
particularly important. Continuing the status quo means not having HIV care transition occur in a 
systematic way, except in isolated cases that are exceptions. Even modest changes in how the 
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HIV care transition process happens in the population of detained, HIV-infected Mexican aliens 
will have an important public health impact. Perhaps one of the key informants put it best: 
The scenario is that this person’s going to be deported from the United States anyway, 
and the best that we can do is to make sure that they receive care in Mexico, that those 
physicians have the best clinical information to make their decisions on how to go 




 While completing this doctoral degree, the investigator was employed by CDC. This 
dissertation was not linked to the work required in this role. The analysis, results, and 
conclusions are the investigator’s work conducted as a student and do not in any way represent 
CDC or the investigator’s work at CDC.   
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APPENDIX B. KEY INFORMANT INTERVIEW GUIDE 
 
Good afternoon, [insert name]. Thank you for agreeing to participate in this study which is a 
component of my doctoral dissertation for the University of North Carolina, Chapel Hill. This 
interview should take 30-40 minutes and will consist of 13 questions.  
 
I am implementing an exploratory research study looking at ways to improve HIV care transition 
for HIV-infected aliens detained by U.S. Immigration and Customs Enforcement and removed to 
Mexico. I am also exploring whether there are lessons that can be learned from tuberculosis care 
transition in this same population. The purpose of the key informant interviews is to enhance my 
understanding of some of the perceptions about HIV care transition in this population and the 
factors that are facilitating or hindering its success. The results of this study will be used to 
inform policy recommendations that may be helpful to address this issue.  
 
The information collected in this interview will be kept completely confidential. Your name will 
not be connected to your answers in any way. Your name will not be used in any study report, 
final report, or publications. Once the data have been compiled, all identifying information 
associated with your answers will be removed.  
 
Your participation in this study is purely voluntary, and there are no consequences if you refuse 
to participate. At any time during our conversation, please feel free to let me know if you have 
any questions or if you would rather not answer a specific question. You can also stop the 
interview at any time for any reason. 
 
With your permission, I would like to record our interview. This will ensure that none of your 
important insights are missed. The audiotape will not have any names on it (only an identifier 
code) and will be kept in a secure location. Tapes and transcriptions will be destroyed at the end 
of the study. The interview will not be recorded if you prefer. If you prefer it not to be, I will take 
detailed notes. 
 
• Before we begin, do you have any questions about the study or the interview? 
• May we record the interview? 
 
[Turn on recording equipment.] 
 
Before we begin, I will review a few terms that will be used in the questions. In order to ensure 
consistency, all terminology used will be consistent with that of the U.S. federal government.  
− Alien refers to any person who is not a citizen or national of the United States. 
− For this specific research project, HIV and tuberculosis care transition refer to the 
coordination and continuity of health care for HIV- and/or active TB-infected aliens removed 
from immigration detention in the United States to Mexico.  
− Removal occurs when the federal government orders that an alien be expulsed from the 
United States. This expulsion may be based on grounds of inadmissibility to the United 
States, such as aliens seeking asylum, or deportability for a violation of immigration law.  
  





1. To start off with, I am going to ask a little bit about you. What is your current 
position? 
2. Can you tell me about your work history engaging with immigration detention 
and/or with detained aliens after their removal from the United States? 
Perceptions of the current quality of HIV care transition for detained HIV-infected aliens 
removed to Mexico and challenges affecting the care transition. 
3. How would you describe the current situation regarding the access detained HIV-
infected aliens have to continued HIV care and treatment in Mexico upon arrival? 
4. How would you characterize the coordination of HIV care transition between U.S. 
and Mexican authorities? How could this cooperation be improved?  
5. What are the most important administrative barriers for HIV-infected aliens to 
access HIV care and treatment in Mexico?  
6. What are the main challenges for continuity of HIV care and treatment in this 
population? 
7. What would an ideal HIV care transition process look like to you? 
Lessons from tuberculosis care transition for removed aliens that can be applied to HIV care 
transition 
8. How would you describe the current situation regarding tuberculosis care transition 
for detained aliens removed to Mexico?   
9. What would an ideal TB care transition process look like to you? 
10. In addition to tuberculosis, are you aware of models of care transition in other 
settings that might provide insights on how to improve HIV care transition in this 
population? [If the respondent asks for an example, options could include persons 
transitioning from prison to the community, military to civilian life, or adolescent to adult 
care.] 
Wrap up and Closing 
11. Is there anything else that you would like to add about any of the topics that we’ve 
discussed or other areas that we didn’t discuss but you think are important? 
12. What is the most important message that you want me to take away from this 
interview? 
13. Do you have any questions for me at this time? 
 
Thank you for taking the time to answer these questions. Your participation in this interview 
greatly contributes to the research project and to increasing our understanding around HIV care 
transition for detained aliens removed to Mexico. Your answers will be compiled with the 
answers of all other interviewees. Please feel free to contact me at any time if you have any 
questions about this interview or the research project.  
 
Addendum to Interview Guide: List of Possible Probes 
• Can you tell me more? (asking for more information) 
• Can you provide more details? (asking for more information) 
• Can you give me another example? (asking for more information) 
• Could you explain your response more? (asking for an explanation) 
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APPENDIX C. INTERVIEW CONSENT FORM 
University of North Carolina at Chapel Hill 
Consent to Participate in a Research Study – Adult Participants  
IRB Study #: 18-2739 
Title of Study: How can HIV care transition be improved when U.S. Immigration and Customs 
Enforcement repatriates detained aliens to Mexico? 
CONCISE SUMMARY 
 
The purpose of this research study is to look at ways to improve HIV care transition for HIV-
infected aliens detained by U.S. Immigration and Customs Enforcement and removed to Mexico. 
The purpose of the key informant interviews is to enhance understanding of some of the 
perceptions about HIV care transition in this populations and factors that are facilitating or 
hindering its success. The results of this study will be used to inform policy recommendations 
that may be helpful to address this issue.  
 
Participants in the telephone interviews will be asked for no more than 60 minutes of their time. 
Each interview should take about 40 minutes. 
 
The greatest risk of this study is the possibility of loss of confidentiality. 
 
If you are interested in learning more about this study, please continue to read below. 
 
What are some general things you should know about research studies? 
You are being asked to take part in a research study. To join the study is voluntary. 
You may choose not to participate, or you may withdraw your consent to be in the study, for any 
reason, without penalty. 
 
Research studies are designed to obtain new knowledge. This new information may help people 
in the future. You may not receive any direct benefit from being in the research study. There also 
may be risks to being in research studies.  
 
Details about this study are discussed below. It is important that you understand this information 
so that you can make an informed choice about being in this research study.  
 
You will be given a copy of this consent form. You should ask the researchers named above, or 
staff members who may assist them, any questions you have about this study at any time. 
 
What is the purpose of this study? 
The purpose of this exploratory research study is to look at ways to improve HIV care transition 
for HIV-infected aliens detained by U.S. Immigration and Customs Enforcement and removed to 
Mexico. The study is also exploring whether there are lessons that can be learned from 
tuberculosis care transition in this same population. The purpose of the key informant interviews 
is to enhance understanding of some of the perceptions about HIV care transition in this 
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population and the factors that are facilitating or hindering its success. The results of this study 
will be used to inform policy recommendations that may be helpful to address this issue.  
 
You are being asked to be in the study because of your level of experience with immigration 
detention in the United States and/or with HIV and/or tuberculosis care transition for detained 
aliens removed to Mexico by U.S. Immigration and Customs Enforcement. 
 
Are there any reasons you should not be in this study? 
You should not be in this study if you are not familiar with immigration detention in the United 
States and/or with HIV and/or tuberculosis care transition for detained aliens removed to Mexico 
by U.S. Immigration and Customs Enforcement. 
 
How many people will take part in this study? 
There will be approximately nine (9) people in this research study. 
 
How long will your part in this study last? 
Your telephone interview should take no longer than 40 minutes to complete; however, you are 
asked to allot 45 to 60 minutes for the interview so that you have the opportunity to elaborate 
when responding to questions.  
 
What will happen if you take part in the study? 
If you decide to participate in an interview, the Principal Investigator will work with you to 
schedule the interview and will ask you to block one hour. The interview will be conducted by 
telephone by the Principal Investigator. 
 
At the beginning of the telephone interview, the Principal Investigator will open by sharing the 
purpose of the interview and the details of the study. The Principal Investigator will ask you for 
your verbal consent to be interviewed. Should you provide your verbal consent to be 
interviewed, the Principal Investigator will then ask for your consent for the telephone interview 
to be recorded. The interview will not be recorded if you prefer. If you prefer it not to be, the 
Principal Investigator will take detailed notes. 
 
The Principal Investigator will then inform you that your name will not be connected to your 
answers in any way. Your name will not be used in any study report, final report, or publications. 
Once the data have been compiled, all identifying information associated with your answers will 
be removed.  
 
At any time during the interview, you can let the Principal Investigator know if have any 
questions or if you would rather not answer a specific question. You can also stop the interview 
at any time for any reason. 
 
The Principal Investigator will ask you if you have any questions about the study or the 
interview. The Principal Investigator will then review several terms with you that will be used in 




What are the possible benefits from being in this study? 
Research is designed to benefit society by gaining new knowledge. You will not benefit 
personally from being in this research study. 
  
What are the possible risks or discomforts involved from being in this study? 
The greatest risk of this study is the potential for loss of confidentiality. Study staff and the 
Principal Investigator will use their best efforts to protect your information and keep it 
confidential, however there is always a risk of disclosure. 
 
How will information about you be protected? 
Your name will not be connected to your answers in any way. You will be issued an ID number 
that will be used for your interview, rather than your name. Your name will not be used in any 
study report, final report, or publications. Once the data have been compiled, all identifying 
information associated with your answers will be removed.  
 
Audio recordings of the key informant interviews will be transcribed; names and other identifiers 
will not be included in the transcribed copies. Electronic copies of transcriptions will be stored 
on password-protected computers on a secure server. Keys linking names and personally 
identifiable information with ID numbers will be destroyed once the database is complete and 
ready for analysis. All data will be on password-protected servers until the study results are 
completed. All field notes will be kept in a locked cabinet in the Principal Investigator’s office. 
Access to print and electronic files will be restricted to the study investigators. When the study 
results are completed, the electronic and paper data will be destroyed. 
 
Although every effort will be made to keep research records private, there may be times when 
federal or state law requires the disclosure of such records, including personal information.  This 
is very unlikely, but if disclosure is ever required, UNC-Chapel Hill will take steps allowable by 
law to protect the privacy of personal information.  In some cases, your information in this 
research study could be reviewed by representatives of the University. 
 
At the beginning of the interview, the Principal Investigator will ask you for your consent for the 
telephone interview to be recorded. The interview will not be recorded if you prefer. If you 
prefer it not to be, the Principal Investigator will take detailed notes. At any point during the 
interview you can request that the audio recording be turned off.  
 
What if you want to stop before your part in the study is complete? 
You can withdraw from this study at any time, without penalty. You can request that the 
interview be stopped at any point. After the interview, you can request that your interview 
responses not be used in the study. 
 
Will you receive anything for being in this study? 
You will not receive anything for taking part in this study. 
 
Will it cost you anything to be in this study? 




What if you have questions about this study? 
You have the right to ask, and have answered, any questions you may have about this research. If 
you have questions about the study, complaints, or concerns, you should contact the researchers 
listed on the first page of this form. 
 
What if you have questions about your rights as a research participant? 
All research on human volunteers is reviewed by a committee that works to protect your rights 
and welfare.  If you have questions or concerns about your rights as a research subject, or if you 
would like to obtain information or offer input, you may contact the Institutional Review Board 
at 919-966-3113 or by email to IRB_subjects@unc.edu. 
  
Participant’s Agreement: 
I have read the information provided above.  I have asked all the questions I have at this time. I 
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